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ABSTRACT 
 
 The Arabidopsis TGA family of basic leucine zipper transcription factors 
regulate the expression of pathogenesis-related genes and are required for resistance to 
disease. Members of the family possess diverse properties in respect to their ability to 
transactivate and interact with NPR1, the central regulator of systemic acquired 
resistance in Arabidopsis. Two TGA factors, TGA1 and TGA2, have 83 % amino acid 
similarity but possess differing properties. TGA1 does not interact with NPR1 but is able 
to transactivate, while TGA2 interacts with NPR1 but is unable to transactivate. This 
study uses these two TGA factors to identify amino acids that are responsible for their 
function.  
Four cysteines residues within TGA1 were targeted for study by site-directed 
mutagenesis and the resulting mutants were tested for interaction with NPR1 in yeast. 
The construct containing a mutation of cysteine 260 (Cys-260) interacted well with 
NPR1, while those with mutations at Cys-172 or Cys-266 interacted poorly. The Cys-
260 mutant also displayed the greatest decrease in transactivation potential in yeast, 
while mutation of Cys-172 or Cys-266 resulted in smaller decreases. Mutation of Cys-
287 had no effect on NPR1 interaction or transactivation. Combining various point 
mutations in a single protein did not increase NPR1 interaction or transactivation levels, 
indicating that Cys-260 is crucial for regulating TGA1 properties. Cysteines possess the 
unique ability of forming reversible disulfide bonds which have been shown to regulate 
several mammalian cellular processes. The observation that mutation of a single TGA1 
cysteine (Cys-260) greatly alters the protein’s properties provides a convincing 
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argument that oxidoreduction of this residue is important for its regulation, possibly 
through the formation of a disulfide bond with either Cys-172 or Cys-266. 
To test whether other members of the TGA family could be regulated by 
oxidoreduction, several TGA2 constructs were created that introduced Cys at positions 
corresponding to those found in TGA1. When tested in yeast none were able to 
transactivate but continued to interact with NPR1.  
 v
TABLE OF CONTENTS 
 
PERMISSION TO USE...................................................................................................... ii 
 
ABSTRACT....................................................................................................................... iii 
 
ACKNOWLEDGEMENTS............................................................................................... iv 
 
TABLE OF CONTENTS................................................................................................... vi 
 
LIST OF TABLES........................................................................................................... viii 
 
LIST OF FIGURES ........................................................................................................... ix 
 
LIST OF ABBREVIATIONS............................................................................................. x 
 
CHAPTER 1: INTRODUCTION ....................................................................................... 1 
 
CHAPTER 2: LITERATURE REVIEW ........................................................................... 3 
2.1 Induced disease resistance ............................................................................................ 3 
2.1.1 Systemic acquired resistance (SAR) ....................................................................... 3 
2.1.1.1 PR Genes........................................................................................................... 4 
2.2 NPR1 (in disease resistance)......................................................................................... 5 
2.3 Other forms of induced disease resistance.................................................................... 7 
2.4 TGA factors in SAR...................................................................................................... 8 
2.4.1 The as-1 element ..................................................................................................... 8 
2.4.2 TGA factors structure and family .......................................................................... 9 
2.4.3 Interaction with NPR1 .......................................................................................... 10 
2.4.4 Functional analysis of TGA factors ...................................................................... 12 
2.5 Redox regulation......................................................................................................... 15 
2.5.1 Redox regulation of transcription factors.............................................................. 17 
2.5.2 Redox regulation of SAR...................................................................................... 18 
2.6 Study Goals ................................................................................................................. 19 
2.6.1 Previous research relevant to the project .............................................................. 19 
2.6.2 Research questions and objectives........................................................................ 21 
 
CHAPTER 3: MATERIAL AND METHODS................................................................. 22 
3.1 Chemicals.................................................................................................................... 22 
3.2 Bacteria and yeast cell methods .................................................................................. 22 
3.2.1 Bacterial and yeast strains..................................................................................... 22 
3.2.2 Bacterial media ..................................................................................................... 23 
3.2.3 Yeast media........................................................................................................... 23 
3.2.4 Cell growth and storage conditions....................................................................... 23 
3.2.5 Plasmid transformation into bacterial cells........................................................... 23 
3.2.5.1 Preparation of electro-competent bacterial cells............................................. 23 
 vi
3.2.5.2 Electroporation of electro-competent bacterial cells ...................................... 25 
3.2.6 Plasmid transformation into yeast cells ................................................................ 25 
3.2.6.1 Preparation of chemically competent yeast cells ............................................ 25 
3.2.6.2 Transformation of chemically competent yeast cells...................................... 26 
3.3 DNA methods ............................................................................................................. 26 
3.3.1 Bacterial Plasmids................................................................................................. 26 
3.3.2 Yeast Plasmids ...................................................................................................... 27 
3.3.3 Extraction of plasmid DNA from bacteria............................................................ 27 
3.3.4 Restriction enzyme digest ..................................................................................... 28 
3.3.5 Agarose gel electrophoresis and recovery of DNA .............................................. 28 
3.3.6 Ligation of DNA fragments into vector DNA ...................................................... 28 
3.3.7 PCR (Polymerase Chain Reaction) amplification................................................. 29 
3.3.8 Introduction of point mutations ............................................................................ 30 
3.3.8.1 Site-directed mutagenesis (SDM) ................................................................... 30 
3.3.8.2 Stitching .......................................................................................................... 30 
3.4 Plasmid construction................................................................................................... 33 
3.5 Enzymatic assays ........................................................................................................ 34 
3.5.1 β-galactosidase assay ............................................................................................ 34 
3.5.2 Quantitative β-glucuronidase (GUS) assay of yeast cells..................................... 34 
3.5.3 Quantitative protein assay..................................................................................... 35 
3.5.4 Statistical analysis of quantified GUS activity ..................................................... 35 
 
CHAPTER 4: RESULTS.................................................................................................. 37 
4.1 Role of cysteine residues in controlling transactivation by TGA1/TGA4 and the 
interaction of TGA factors with NPR1 ......................................................................... 37 
4.1.1 Role of TGA1 cysteines within the 30 amino acid domain .................................. 37 
 4.1.1.1 Quantitative analysis of transactivation for TGA1 mutants with altered 
cysteines within the 30 amino acid region............................................................ 42 
4.1.2 Role of TGA4 cysteines within the 30 amino acid region.................................... 46 
4.1.3 Role of TGA1 cysteines outside of the 30 amino acid domain ............................ 47 
4.1.3.1 Quantitative analysis of transactivation of TGA1 mutants in cysteines 
outside the 30 amino acid region .......................................................................... 48 
4.1.4 Simultaneous mutation of multiple cysteines in TGA1........................................ 49 
4.1.4.1 Quantitative analysis of transactivation for TGA1 with mutations at 
multiple residues ................................................................................................... 50 
4.2 Attempts to alter transactivation and NPR1 interacting properties of TGA2............. 53 
4.3 Attempts to identify a trans-repression domain in TGA2........................................... 55 
 
CHAPTER 5: DISCUSSION............................................................................................ 59 
5.1 Cysteines 260 and 266 of TGA1 affect interaction with NPR1.................................. 60 
5.2 Cys260 and Cys266 affect TGA1’s ability to transactivate........................................ 64 
5.3 The affect of the other cysteines in TGA1.................................................................. 68 
5.4 TGA2 properties ......................................................................................................... 72 
 
CHAPTER 6: REFERENCES .......................................................................................... 75 
 
 vii
LIST OF TABLES 
 
CHAPTER 3: MATERIAL AND METHODS 
Table 3.1 Media used in this study ................................................................................... 24 
Table 3.2 Antibiotics used in this study............................................................................ 24 
Table 3.3 Oligonucleotides used for PCR amplification and sequencing......................... 31 
 viii
LIST OF FIGURES 
 
 
CHAPTER 2: LITERATURE REVIEW 
 
Figure 2.1 Dendrogram of Arabidopsis TGA factors ........................................................... 11 
 
CHAPTER 4: RESULTS 
 
Figure 4.1 Transactivation and NPR1-interaction properties of TGA1 containing 
mutations within the 30 amino acid region........................................................................... 38 
Figure 4.2 Alignment of seven of the Arabidopsis TGA factors .......................................... 39 
Figure 4.3 β-galactosidase assay results for TGA1 and TGA4 site-directed mutants used 
in this study. .......................................................................................................................... 41 
Figure 4.4 Quantitative GUS assay of transactivation of TGA1 with mutation of the 
cysteine residues ................................................................................................................... 44 
Figure 4.5 Quantitative GUS assay of transactivation of TGA1 with mutation at multiple 
cysteine residues ................................................................................................................... 52 
Figure 4.6 β-galactosidase assay results for TGA1/TGA2 chimeric and site-directed 
mutants used in this study ..................................................................................................... 54 
Figure 4.7 β-galactosidase assay results for TGA1/TGA2 chimeric and site-directed 
mutants used in this study ..................................................................................................... 58 
 
CHAPTER 5: DISCUSSION 
 
Figure 5.1 A model depicting redox control of TGA1 on binding activity (modified from 
Després et al., 2003).............................................................................................................. 65 
 
 ix
LIST OF ABBREVIATIONS 
 
°C  degrees centigrade 
%  percentage 
µ  micro- 
A  asparagine 
ACD2   accelerated cell death2 
ARD   ankyrin repeat domain  
as-1  activating sequence 1 
Asn   asparagine  
BABA  β-aminobutyric acid  
bla   β-lactamase gene 
BTB/POZ  broad-complex, tramtrack, and bric-a-brac/pox virus and zinc finger 
BTH  benzol (1,2,3) thiadiazole-7-cabothionic acid S-methyl ester 
bZIP  basic leucine zipper 
C  cysteine 
c   centi-  
CaMV  Cauliflower Mosaic Virus 
cat   chloramphenicol acetyltransferase gene 
Cruc  cruciferin 
Cys  cysteine  
DB  DNA-binding domain 
DNA  deoxyribonucleic acid 
EDTA  ethylenediamine-tetraacetic acid  
EMSA  electromobility shift assay 
f  femto- 
F  phenylalanine 
FD  Faraday 
g  gram(s) 
GST-6  glutathione S-transferase6  
GSH  reduced glutathione 
 x
GSSG  oxidized glutathione 
GUS  β-glucuronidase 
HR  hypersensitive response 
hr  hour(s) 
INA  2,6-dichloroisonicotinic acid  
ISR  induced systemic resistance 
l  litre(s) 
LacZ   β-galactosidase gene  
Leu  leucine 
Li   lithium  
LS   linker scan 
K  kilo- 
m   milli-, meter(s) 
M  molar 
min  minute(s)  
mol  moles 
MU  methyl-umbelliferone 
MUG  methyl-umbelliferyl-β-D-glucuronide 
n  nano-  
NH1  NPR1 homolog1 
NIM1   non-inducible immunity1 
NLS  nuclear localizing signal 
npt   neomycin phosphotransferase  gene 
NPR1  non-expresser of pathogenesis-related genes1 
nos  nopaline synthase 
OBF  octopine binding factors  
ocs  octopine synthase  
ODx   absorbance at wavelength (x) 
PEG  polyethylene glycol 
PCR  polymerase chain reaction 
pH  percentage of hydrogen 
 xi
PR  pathogenesis-related 
pv  pathovar 
ROS   reactive oxygen species  
RNAi  RNA interference 
rpm  revolutions per minute 
S  serine 
SA  salicylic acid 
SAR  systemic acquired resistance 
Ser  Serine 
SD  synthetic dextrose 
Sd  standard deviation 
SDM  site-directed mutagenesis 
SDS  sodium dodecyl sulphate  
sec  second(s) 
TA  transcriptional activation domain 
TAE  Tris, sodium acetate, and EDTA 
Ti   tumour-inducing  
TE  Tris buffer and EDTA 
Trp  tryptophan 
UAS   upstream activator sequences 
uidA   β-glucuronidase gene (GUS)  
V  volt(s) 
VIGS  virus-induced gene silencing 
X-GAL 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
 xii
CHAPTER 1: INTRODUCTION 
 
All plants possess a variety of mechanisms that prevent the establishment of 
disease by pathogens. The first line of defence includes constitutive barriers, such as 
waxes, lignin, suberin and phytoanticipins, which the pathogens must overcome in order 
to infect the plant tissue. In many cases these barriers are sufficient to repel the 
pathogen, but in the event that the constitutive barriers fail another line of resistance is 
required. Several forms of induced responses, triggered during or immediately after 
pathogen infection, exist and the results are wide and varied. These secondary defence 
reactions include the production of antimicrobial compounds, programmed cell death (in 
the form of the hypersensitive response, HR) and cell wall modifications (Mysore and 
Ryu, 2004; Veronese et al., 2003).  
It is important to consider that the crux of induced disease responses lies in the 
ability of the plant to coordinate the transcription of perhaps thousands of genes with the 
sole purpose of achieving a disease resistant state (Katagiri, 2004). In Arabidopsis the 
identification of genes affected transcriptionally by disease or by chemical elicitors, 
which induce a disease response, has increased substantially by the advent of large-scale 
gene expression profiling studies (Katagiri, 2004; Wan et al., 2002). These studies 
indicate that as much as 25% of the genes identified in Arabidopsis are affected at the 
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transcriptional level by pathogen infection. Although many studies are underway to 
explore these genes, assigning a function, with regard to defence responses, will take 
many years.  
The study of transcription factors that regulate these genes is just one of the 
many methods employed to study the phenomenon of transcriptional regulation in 
response to pathogen challenge. Plants devote many genes to the regulation of 
transcription, with over 1500 transcription factors encoded by the Arabidopsis genome 
alone (Riechmann et al., 2000). Numerous transcription factors have been identified as 
possessing a role in plant disease resistance (Euglem, 2005; Rushton and Somssich, 
1998). Understanding the targets and the regulatory mechanisms of these transcription 
factors during pathogen infection should facilitate studies targeting key genes in defence 
response. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Induced disease resistance 
In addition to the immediate defence responses described in the introduction, 
exposure to a pathogen can also confer broad spectrum long-term resistance against 
subsequent infection. These responses have been termed induced disease resistance and 
have been observed and studied in plants for a century. Three forms of induced disease 
resistance have been identified in plants, each unique in the spectrum of pathogen 
protection and the gene expression cascade resulting in resistance.   
2.1.1 Systemic acquired resistance (SAR) 
The most commonly referred to and studied form of induced disease resistance is 
systemic acquired resistance (SAR). SAR, identified in a variety of monocots and dicots, 
occurs in response to microbes able to cause necrosis, be it the HR or as part of the 
disease process (Durrant and Dong, 2004; Sticher et al., 1997). The resulting enhanced 
resistant state of systemic plant tissues extends to a broad range of pathogens including 
bacteria, fungi and viruses (Sticher et al., 1997). 
A key element to the establishment of SAR in a plant is the accumulation of the 
small stress molecule salicylic acid (SA; Ryals et al., 1996). Mutants in which SA 
production or accumulation is inhibited are compromised in their ability to mount SAR 
(Dewdney et al., 2000; Nawrath and Metraux., 1999). Conversely, exogenous 
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application of SA or SA analogs such as benzol (1,2,3) thiadiazole-7-cabothionic acid S-
methyl ester (BTH) or 2,6-dichloroisonicotinic acid (INA) instigates a SAR-like reaction 
and will restore the SAR pathway in mutants deficient in SA (Parker et al., 1996; Uknes 
et al., 1992; Ward et al., 1991).  
2.1.1.1 PR Genes 
SAR is characterized at the molecular level by the accumulation of a group of 
proteins called pathogenesis-related (PR) proteins (Uknes et al., 1992; Ward et al., 
1991). PR proteins are structurally diverse and possess various functions within, or 
outside of, the plant cell (Van Loon and Van Strien, 1999). While several PR proteins 
have been identified to possess antimicrobial properties (e.g. chitinases, β-1,3-
glucanases), a function for the majority of PR proteins in response to disease has not yet 
been determined.  
PR proteins begin to accumulate in local and systemic tissues soon after 
pathogen infection and levels may increase for several hours or days (Van Loon and Van 
Strien, 1999). Because they are reliably induced in pathogen infection, transcripts of PR 
proteins are widely used as molecular markers for SAR. It is important to note that the 
type of PR proteins and the level of their accumulation are specific to the plant-pathogen 
interaction; therefore marker genes must be determined on an individual plant-pathogen 
basis. In Arabidopsis, PR-1 is widely used as a marker of SAR (Durrant and Dong, 
2004). It is the coordinated expression of multiple PR genes that is thought to account 
for the broad-spectrum resistance observed as SAR. Mutants in which PR gene 
expression is abolished, like npr1 (non-expresser of PR genes1; Cao et al., 1994), 
display increased susceptibility to disease whereas mutants that constitutively express 
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PR genes like acd2 (accelerated cell death2; Dietrich et al., 1994), display enhanced 
resistance to disease. 
2.2 NPR1  
Screening for mutants has proven to be a useful technique for identifying genes 
involved in the SAR signalling pathway. The study of several SAR-deficient mutant 
phenotypes led back to the same gene designated npr1 or nim1 (non-inducible 
immunity1; Shah et al., 1997; Glazebrook et al., 1996; Delaney et al., 1995; Cao et al., 
1994). In addition to being compromised in SAR, npr1 mutants are also defective in 
basal resistance, Induced Systemic Resistance (ISR, see section 2.3), and gene-for-gene 
resistance against specific races of pathogens (Pieterse et al., 1998).  
Two features of npr1 mutants help place the gene in the complicated defence 
gene signalling cascade. The observation that npr1 mutants accumulate normal levels of 
SA and that the mutant phenotype cannot be rescued by exogenous SA (Delaney et al., 
1995; Cao et al., 1994) indicates that NPR1 is located downstream of this metabolite in 
the signalling pathway. npr1 mutants also do not activate PR genes or accumulate PR 
proteins subsequent to treatment with SAR elicitors including pathogen infection 
(Delaney et al., 1995; Cao et al., 1994). This indicates that NPR1 is located upstream of 
PR gene expression in the signalling pathway.  
The NPR1 gene encodes a protein containing two protein-protein interaction 
motifs: a BTB/POZ (Broad-Complex, Tramtrack, and Bric-a-brac/Pox virus and Zinc 
finger) as well as an Ankyrin Repeat Domain (ARD; Cao et al., 1997; Ryals et al., 
1997). Several mutant alleles have been mapped to conserved amino acids found within 
the ARD of NPR1, suggesting an important role for this motif during disease resistance. 
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Only one mutant allele has been mapped to an amino acid within the BTB/POZ domain 
(npr1-2), but as the particular amino acid affected is located within a non-conserved 
region of the BTB/POZ (Després, unpublished observation) no conclusions can be 
drawn about the significance of the motif during disease resistance.  
Overexpression studies of the Arabidopsis NPR1 gene in Arabidopsis, tomato 
and rice all report plants with increased resistance to a range of pathogens (Lin et al., 
2004; Chern et al., 2001; Friedrich et al., 2001; Cao et al., 1998). The levels of NPR1 in 
these transgenic lines do not necessarily correlate to the level of disease resistance 
observed, therefore it has been proposed that a threshold level of NPR1 may be required 
for enhanced disease resistance (Lin et al., 2004; Chern et al., 2001). Most of these 
transgenic lines do not constitutively express PR genes, therefore the observed enhanced 
resistance appears to be due to either stronger PR gene expression (Cao et al., 1998), or 
to faster PR gene expression (Friedrich et al., 2001) in response to pathogen infection. In 
contrast, rice plants overexpressing NH1, a homolog of NPR1, do constitutively express 
PR genes (Chern et al., 2005). Rice plants overexpressing (At)NPR1 or NH1 are unique 
in that under certain growth conditions, spontaneous disease-like lesions develop and 
hydrogen peroxide accumulates while SA levels may increase or decrease (Chern et al., 
2005; Fitzgerald et al., 2004). The changes observed in the SA levels may indicate that 
NPR1 is involved in the perception and modulation of SA. 
The lack of constitutive PR gene expression in NPR1 overexpressors may be 
linked to the cellular localization of the protein in non-elicited cells. In resting cells 
NPR1 is found throughout the cell, but when the cell is treated with an elicitor NPR1 is 
translocated to the nucleus (Després et al., 2000; Kinkema et al., 2000). Nuclear 
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localization of NPR1, which is mediated by a Nuclear Localization Signal (NLS) found 
in the C-terminus, is required for PR gene expression (Kinkema et al., 2000). NPR1 does 
not contain a recognizable DNA binding motif suggesting that it does not function as a 
transcription factor. In fact interaction between NPR1 and a group of basic leucine 
zipper (bZIP) transcription factors called TGA factors is required for PR gene 
expression and SAR (Fan and Dong, 2002; Després et al., 2000; Zhou et al., 2000; 
Zhang et al., 1999; see section 2.4 for information on TGA factors). Translocation of 
NPR1 to the nucleus and interaction with TGA factors appear to be regulated 
posttranslationally through redox changes of conserved cysteine (Cys) residues (Mou et 
al., 2003; see section 2.5.2).  
2.3 Other forms of induced disease resistance 
Another well studied form of induced resistance is termed Induced Systemic 
Resistance (ISR). ISR occurs in response to soil borne rhizobacteria which triggers 
pathogen resistance in aerial plant parts (Van Loon et al., 1998). ISR has been identified 
in a variety of plant species and provides resistance against a variety of pathogens (Ton 
et al., 2002; Pieterse et al., 1998; Van Loon et al., 1998). ISR is also markedly different 
from SAR in that SA is not required for resistance; rather the response requires jasmonic 
acid and ethylene, and that PR gene expression is not observed. Interestingly, ISR does 
require functional NPR1 (Pieterse et al., 1998; Cao et al., 1994). 
The third type of resistance was discovered relatively recently and therefore has 
not been as well studied as the former two. BABA resistance consists of a priming 
mechanism initiated by treating the plants with the non-protein amino acid β-
aminobutyric acid (BABA; Jakab et al., 2005; Zimmerli et al., 2000). Plants treated with 
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BABA respond to pathogen infection by rapidly increasing the expression of PR genes. 
Another feature that sets BABA resistance apart from the other two types is the ability to 
not only protect the plant from biotic stress but also from abiotic stress (Jakob et al., 
2005). 
One of the underlying themes of induced disease resistance in the last few years 
is the cross-talk that exists between the three types of resistance. Although each appears 
to have its unique characteristics, genes and molecules that were once thought to be 
exclusive to one type of resistance appear to also possess a role in one or both of the 
other types (Pieterse and Van Loon, 2004). 
2.4 TGA factors in SAR 
2.4.1 The as-1 element 
 TGA factors were first identified through their ability to bind to the activating 
sequence 1 (as-1) element of the Cauliflower Mosaic Virus (CaMV) 35S promoter 
(Katagiri et al., 1989). It is from the as-1 element, composed of two TGACG motifs 
spaced eight nucleotides apart, that TGA factors derive their name. Research done 
concurrently found that TGA factors were also able to bind a similar element found in 
the octopine synthase (ocs) promoter from the Agrobacterium tumefaciens tumour-
inducing (Ti) plasmid (Fromm et al., 1989). Consequently some of the TGA factors 
were first referred to as Octopine Binding Factors (OBF) (Zhang et al., 1993); however 
they will be referred to as TGA factors in this thesis. 
 The as-1 element has been found to be important in the regulation of glutathione 
S-transferase 6 (GST-6) (Strompen et al., 1998) as well as PR-1 (Lebel et al., 1998). It 
has also been found to be over-represented in the promoters of genes differentially 
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expressed under abiotic stress and pathogen infection (Mahalingam et al., 2003). The as-
1 element appears to respond to a number of phytohormones such as SA, methyl 
jasmonate and auxins (Xiang et al., 1996). 
Further investigation into the PR-1 promoter found that it contains two putative 
TGA factor binding targets termed linker scan7 (LS7) and LS5 (Lebel et al., 1998). 
These elements act as positive and negative regulators, respectively, of PR-1 expression 
in response to INA or SA treatment. TGA2 is able to interact with both of these 
elements, and interestingly NPR1 enhances this binding in vitro (Després et al., 2000), 
which may provide the link between NPR1 and TGA factors relative to a role during 
disease. Thus far NPR1 does not appear to enhance the DNA-binding properties of those 
TGA factors in which protein interaction has not yet been established. 
2.4.2 Structure and family of TGA factors 
Sequence analysis of the first TGA factors isolated from tobacco identified a 
Basic Leucine Zipper (bZIP) (Jakoby et al., 2002; Katagiri et al., 1989). The bZIP is 
composed of ~16 basic amino acids, a spacer of nine amino acids followed by a heptad 
repeat of either leucines or any bulky hydrophobic amino acid (Jakoby et al., 2002). 
These structures, located on an α-helix, allow for the interaction between proteins via 
the hydrophobic sides of the helices. Therefore creating a coiled-coil structure otherwise 
called “the zipper”. As a dimer the proteins interact with the DNA through the basic 
region preferring sequences with an ACGT core, such as the A-box (TACGTA), C-box 
(GACGTC) and G-box (CACGTG).  
Transcription factors containing a bZIP have been identified in plants and 
mammals (Riechmann et al., 2000) and participate in a variety of tasks in plants from 
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pathogen defence (Kim and Delaney, 2002) to floral development (Wigge et al., 2005). 
In Arabidopsis alone over 80 members have been identified. These genes have been 
compiled into ten groups based on sequence similarity of the basic region and the 
presence of additional conserved motifs; TGA factors make up one group (Jakoby et al., 
2002).  
The Arabidopsis TGA family consists of 10 members. Seven of these members 
have been grouped according to amino acid sequence similarity into three subclasses 
(Figure 2.1; Xiang et al., 1997). These subclasses possess little or no similarity to each 
other at the N-terminal end (before the bZIP) while a high degree of similarity is found 
at the C-terminal end. Furthermore the members within a subclass possess similar DNA-
binding specificities, expression patterns, transactivational properties and protein-protein 
interactions (Schiermeyer et al., 2003; Després et al., 2000; Niggeweg et al., 2000a; 
Niggeweg et al., 2000b; Zhou et al., 2000; Zhang et al., 1999).  
2.4.3 Interaction with NPR1 
Interest in TGA factors with regard to their functions in the SAR pathway first 
emerged when they were identified to interact with NPR1 in yeast-two hybrid screens 
(Després et al., 2000; Zhou et al., 2000; Zhang et al., 1999). Using this system, four 
TGA factors (TGA2, 3, 5, 6 and 7) were found to interact with NPR1, while three 
(TGA1, TGA4 and PERIANTHIA) did not interact or interact only very weakly 
(Hepworth et al., 2005; Després et al., 2000; Zhou et al., 2000). The remaining two TGA 
factors have not yet been tested. For two Arabidopsis TGA factors (TGA2 and 5) 
interaction with NPR1 has been confirmed using in vitro binding assays (Després et al., 
2000; Zhang et al., 1999). TGA2 has also been shown to interact with NPR1 in planta
 10
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Figure 2.1 Dendrogram of Arabidopsis TGA factors. 
Seven members of the TGA family have been divided into three subclasses based on 
amino acid sequence similarity. 
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(Fan and Dong, 2002; Subramaniam et al., 2001). Interestingly, the interaction between 
these two proteins was stimulated by treatment with SA, where it was localized 
primarily to the nucleus (Subramaniam et al., 2001).  Arabidopsis TGA factors do not 
interact with the NPR1 mutants when tested either in yeast, in vitro (Després et al., 
2000; Zhang et al., 1999) or in planta (Subramaniam et al., 2001). As these are the same 
NPR1 mutations that compromise SAR, these results provide an argument that TGA 
factors may play an integral role in the SAR pathway.   
Although demonstrating stable interaction between NPR1 and TGA factors in 
planta has proven elusive there is compelling evidence that NPR1 moderates TGA 
binding to its cognate promoter. Chromatin immunoprecipitation (ChIP) studies 
confirmed that TGA2 and TGA3 bind to the PR-1 promoter in planta (Johnson et al., 
2003). This binding is observed only after SA treatment and is abolished in npr1 plants. 
This not only provides evidence indicating that TGA factors possess a role in the SAR 
pathway but that a functional NPR1 is required for TGA function. Després et al. (2000) 
demonstrated this further by showing that binding of TGA2 to the LS5 and LS7 elements 
in the PR-1 promoter in vitro is strengthened by the presence of NPR1. It is important to 
note that this increased binding affinity is not seen with either TGA1 or TGA4, the two 
TGA factors that do not interact with NPR1 in yeast, nor is it observed with NPR1 
mutants that compromise SAR. Based on this evidence, it would appear that members of 
the TGA family are differentially regulated depending on their interaction with NPR1.  
2.4.4. Functional analysis of TGA factors 
  Determining the function of TGA factors during SAR has proven to be a 
complex task. To date only one study has been published with meaningful data on the 
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overexpression of a single member of the family. Kim and Delaney (2002) found that by 
overexpressing TGA5, Arabidopsis plants displayed enhanced resistance to a virulent 
strain of the oomycete Peronospora parasitica while at the same time exhibited 
decreased levels of PR genes. This same study reported that overexpression of another 
member of the TGA family (TGA2), had no effect on disease resistance or PR gene 
expression.  
Attempts to obtain results from plants containing mutations in an individual TGA 
factor have proven to be difficult. It appears that to effectively study TGA function using 
this approach, one cannot target a single member of the family but must instead include 
as many genes as are grouped in individual subclasses (see Section 2.4.2). Perhaps the 
most profound example of this was found in a study done on the triple loss-of-function 
mutant tga2,tga5,tga6 (Zhang et al., 2003). This study also provides the most 
compelling evidence for the involvement of TGA factors in SAR. The triple mutant 
possesses many similarities to the npr1 mutant in that exogenous application of SA or 
INA does not increase PR gene expression, and it is deficient in SAR against P. 
parasitica and the bacterial pathogen Pseudomonas syringae. These phenotypes were 
not observed in the loss-of-function mutants tga6 or tga2,tga5. The compelling evidence 
that the function of members of Subclass II is not only redundant but also involved in 
SAR lies in the fact that either TGA2 or TGA5 is able to rescue the triple mutant 
phenotype.  
The use of dominant-negative versions of TGA factors has been frequently 
utilized in the study of TGA function in planta. Dominant-negative studies rely on 
overexpressing a null variant of a chosen protein that by design supersedes the function 
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of the wild type protein. It would be expected that the resulting transgenic plant exhibits 
a phenotype similar to that of a plant containing a loss-of-function mutation in the gene 
encoding the chosen protein. The use of dominant-negatives is beneficial in studying 
protein families as the null variant may not only supersede the function of its intended 
protein but also that of proteins that are structurally similar or with which it interacts. 
The greatest drawback of using dominant-negatives has been the vastly conflicting 
results between studies which have yet to be convincingly rectified. Expression of 
dominant-negative forms of the Arabidopsis TGA2 gene resulted in Arabidopsis plants 
that were compromised in basal resistance against P. syringae pathovar (pv) maculicola 
(Fan and Dong, 2002) while another study found that tobacco plants, also expressing 
dominant-negative Arabidopsis TGA2, possessed enhanced SAR against P. syringae pv. 
tabaci (Pontier et al., 2001). Each study evaluated the expression of SAR marker genes 
containing an as-1 element in their promoters. These genes fall into one of two 
categories based on the timing of their expression subsequent to SA treatment; early 
genes or late genes. In the case where Arabidopsis plants were compromised in basal 
resistance levels of PR-1, a classical gene used for the late gene category, was reduced 
(members of the early gene category were not tested; Fan and Dong, 2002), whereas in 
tobacco, where enhanced SAR was observed, levels of PR-1a was increased while 
expression of early genes were decreased (Pontier et al., 2001). Expression of a 
dominant-negative version of the tobacco gene TGA2.2 resulted in decreased expression 
of early and late genes (Niggeweg et al., 2000b), while transgenic plants overexpressing 
the wild type TGA2.2 which displayed decreased expression of early genes and no 
change in the expression of PR-1a. Expression of a dominant-negative version of a 
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closely related tobacco gene TGA2.1 resulted in decreased expression of early genes and 
transgenic plants overexpressing the wild type TGA2.1, resulted in decreased expression 
of early genes was observed. In both cases no change in the expression of PR-1a was 
observed (Kegler et al., 2004). A recurring result from most of these studies is the 
observation that TGA2 has a differential effect on early and late marker genes. Together 
results with dominant-negative TGA factors suggest that these proteins may possess 
both positive and negative roles in disease resistance (Pontier et al., 2001). 
Gene silencing, a term that encompasses a variety of methods whose end result is 
to prevent the formation of target proteins, has been less commonly used to study TGA 
function. RNA-interference (RNAi), a method that targets degradation of the RNA of a 
chosen gene, revealed that reducing levels of TGA4 reduced, while reducing levels of 
TGA5 enhanced, the response of a transgenic reporter gene under the control of an ocs -
containing promoter (Foley and Singh, 2004). These authors did not report any 
differences in the expression of endogenous genes containing as-1 elements in their 
promoters, nor did they test the transgenic plants for changes in disease resistance. Using 
virus-induced gene silencing (VIGS), another method that targets the degradation of the 
RNA of a chosen gene, the tomato genes TGA1a and TGA2.2 were shown to be required 
for Pto-mediated resistance to P. syringae pv. tomato harboring avrPto (Ekengren et al., 
2003).  
2.5 Redox regulation 
 Redox regulation of cellular processes is defined by the reduction and/or 
oxidation of molecules, including proteins. The most well known form of redox 
regulation is the devastating results that occur when Reactive Oxygen Species (ROS) 
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accumulate beyond the ability of the cell to buffer against these changes, hence 
producing a state of oxidative stress and resulting in the formation of non-specific 
disulfide bonds in cytoplasmic proteins that causes irreversible damage (Berlett and 
Stadtman, 1997; Sies, 1991). Traditionally disulfide bonds were thought to be stable and 
to help with protein folding and enhancing the stability of exported proteins 
(Wedemeyer et al., 2000; Darby and Creighton, 1995). Work in non-plant systems in the 
last ten years has revealed that the reversible formation of disulfide bonds is used 
extensively to regulate cellular reactions (Shelton et al., 2005; Toledano et al., 2004).  
Disulfide bond formation within proteins is dependent on the redox status of the 
surrounding environment, resulting in their uneven distribution within cells. The 
cytoplasm is generally a reducing environment leading to minimal disulfide bond 
formation compared to the oxidative environments of the periplasm in prokaryotes or the 
endoplasmic reticulum in eukaryotes (Darby and Creighton, 1995). Two cytosolic 
pathways have been identified that regulate disulfide bond formation; the thioredoxin 
and glutaredoxin-glutathione pathways (Ortenberg and Beckwith, 2003; Ritz and 
Beckwith, 2001). The thioredoxin pathway reduces disulfide bonds by direct thiol-
disulfide exchange reactions between the protein and small oxidoreductases known as 
thioredoxins (Ortenberg and Beckwith, 2003). The resulting oxidized thioredoxins are 
then reduced by thioredoxin reductase, which is reduced by NADPH. The glutaredoxin-
glutathione pathway reduces disulfide bonds using a small reduced tripeptide glutathione 
(GSH) to form mixed glutathione-disulfide adducts (Ritz and Beckwith, 2001). These 
are then resolved by glutaredoxins to form oxidized glutathione (GSSG), which is then 
reduced by glutathione oxidoreductase. The ratio of GSH:GSSG is critical for 
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maintaining the reducing environment of the cytoplasm and it appears that it is this ratio  
that acts as the switch to regulate disulfide bond formation.  
2.5.1 Redox regulation of transcription factors 
Two proteins from Escherichia coli, OxyR and SoxR, have been instrumental in 
expanding the understanding of redox regulation of transcription factors. OxyR regulates 
antioxidant defence (Christman et al., 1989). Upon exposure to hydrogen peroxide 
(H2O2) OxyR induces transcription of regulatory proteins, including the small non-
coding regulatory protein oxyS, as well as enzymes that degrade peroxides that balance 
the redox environment of the cell (Zheng et al., 2001; Aslund et al., 1999; Storz and 
Tartaglia, 1992). OxyR possesses an N-terminal DNA binding domain, a C-terminal 
regulatory domain and six conserved cysteines that confer redox sensitivity (Kullik et 
al., 1995a; Kullik et al., 1995b). Under normal reducing conditions, OxyR’s cysteines 
are all reduced and the protein is bound to DNA in a tetrameric form that does not 
interact with RNA polymerase, thus preventing it from transactivating target genes. 
During oxidative stress OxyR cysteines are modified in such a way as to alter protein 
conformation and allowing interaction with RNA polymerase and initiating 
transcription. Of the six cysteines present only one (Cys-199) is crucial for transcription. 
Mutants at this residue are locked in a reduced state resulting in a H2O2 hypersensitive 
phenotype similar to OxyR knockouts. Of the remaining Cys residues only one, Cys-208, 
appears to possess properties that affect transcription (Zheng et al., 1998; Kullik et al., 
1995b). Under strong oxidizing conditions caused by H2O2 a disulfide bond has been 
observed between Cys-199 and Cys-208 (Aslund et al., 1999; Zheng et al., 1998), but as 
 17
Cys-199 is the more important residue it has been hypothesized that it is the initial target 
of H2O2.  
The R1R2R3 family of MYB transcription factors provides an interesting 
example of cross-kingdom redox regulation. The vertebrate R1R2R3 family and plant 
R2R3 family must be reduced for DNA-binding to occur (Williams and Grotewold, 
1997; Grasser et al., 1992; Guehmann et al., 1992).  In vertebrates this property has been 
attributed to a single Cys residue, Cys-130, that acts as a redox sensor, as it is required 
for DNA-binding and transactivation. This residue is conserved in the plant R2R3 family 
but does not appear to possess the same significance as in vertebrates. The 
corresponding residue, Cys-53, in maize P1, a regulator of flavenoid biosynthesis, is not 
required for the protein to bind DNA or to activate transcription (Heine et al., 2004). A 
second Cys residue, Cys-49, appears to be the residue that senses the redox state. 
Another difference between these families is the presence of a disulfide bond between 
Cys-49 and Cys-53 of P1 where the vertebrate family has only one Cys residue.  
Other well-known mammalian transcription factors, including p53, NF-κB, AP-1 
and nuclear receptors have also been shown to be regulated by redox conditions 
(Nishiyama et al., 2001). Typically, changing redox conditions affect the DNA-binding 
properties of these transcription factors, although transactivation and nuclear localization 
may also be affected.  
2.5.2 Redox regulation of SAR 
 
The best known form of redox involvement during disease is the oxidative burst 
that immediately follows pathogen infection (Lamb and Dixon, 1997). The oxidative 
burst is characterized by the accumulation of ROS which in turn trigger cross-linking in 
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the cell wall, HR, as well as act as signals for gene expression. During SAR, transient 
microbursts of H2O2 production have been detected in distal (systemic) tissues (Alvarez 
et al., 1998). These were shown to be required for SAR manifestation.  
The use of redox through the formation of disulfide bonds to regulate SAR in 
plants has only recently been established (Mou et al., 2003). The use of non-reducing 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) showed that 
in an unelicited sample, NPR1 is present throughout the cells in oligomeric form, 
whereas in an INA-treated sample, NPR1 is present mainly in the nucleus in a 
monomeric form. Site-directed mutagenesis confirmed two cysteines within NPR1, Cys-
82 and Cys-216, were key for INA-induced monomerization. Mutation of these Cys 
residues mimics a reduced state where mutated NPR1 is constitutively found as 
monomer in the nucleus and PR-1 gene expression is observed without any elicitors such 
as INA. Treatment with SA was also reported to lead to an increase in the amount of 
GSH, as well as an increase in the ratio of GSH:GSSG (Mou et al., 2003). Based on 
these results, it was proposed that pathogen-induced increases in SA lead to the 
reduction of NPR1 Cys-82 and Cys-216, triggering monomerization and the subsequent 
nuclear localization. 
2.6 Study Goals 
2.6.1 Previous research relevant to the project 
Using NPR1 fused to the GAL4 DNA-binding domain (GAL4-DB) as bait seven 
Arabidopsis TGA factors fused to the GAL4 transactivation domain (GAL4-TA) have 
been tested for protein interaction (Després et al., 2000; Zhou et al., 2000). All factors, 
other than TGA1 and TGA4, were found to interact with NPR1 (Després et al., 2000; 
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Zhou et al., 2000). To determine the region of TGA factors required for interaction with 
NPR1, a series of chimeric proteins were constructed between TGA1 and TGA2, a 
protein that is similar to TGA1 in primary sequence but capable of interacting with 
NPR1 in yeast. A chimeric protein that consists of the N and C-terminal regions of 
TGA1 and only 30 amino acids of TGA2 was found to interact with NPR1, indicating 
that this 30 amino acid region contains sequences important for interaction with NPR1 
(Després et al., 2003). 
Testing of GAL4-DB fusions indicated that only TGA1 and TGA4 were capable 
of autonomous transactivation in yeast (Stonehouse, 2002). To determine the regions 
involved in mediating transactivation the same series of TGA1/TGA2 chimeric proteins 
referred to above were analyzed. The same chimeric protein that consists of the N and 
C-terminal regions of TGA1 and only 30 amino acids of TGA2 was unable to 
transactivate, indicating that the corresponding 30 amino acid region of TGA1 contains 
sequences important for transactivation. Interestingly, this is the same 30 amino acid 
region that was identified as being important for interaction with NPR1 (Després et al., 
unpublished). 
In addition to the chimeric approach detailed above, deletion analysis of the 
Arabidopsis TGA1 was also performed to identify regions responsible for 
transactivation (Stonehouse, 2002; Fobert et al., unpublished data). The N-terminal 
region of TGA1a, a tobacco homolog, has been found to be sufficient for transactivation 
(Niggeweg et al., 2000), but Stonehouse (2002) found that the N-terminal of Arabidopsis 
TGA1 is necessary but not sufficient for transactivation. A chimeric protein that 
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consisted of the N-terminus of TGA2 and the C-terminus of TGA1 did not transactivate 
indicating that N-terminus of TGA1 contains a transactivation domain.  
2.6.2 Research questions and objectives  
The main objectives of this study were to identify regions, and if possible, 
individual amino acids required for TGA2 interaction with NPR1 as well as for 
transactivation of TGA1, by focusing on the 30 amino acid domain from the chimeric 
TGA1/TGA2 protein described above. Using site-directed mutagenesis I intend to 
mutate the two Cys residues found in the 30 amino acid region of TGA1 and test the 
mutant constructs in yeast for NPR1 interaction and transactivation. Because of 
cysteine’s unique ability to form disulfide bonds I also intend to study the remaining two 
Cys residues found in TGA1 by using the same methods.  
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CHAPTER 3: MATERIAL AND METHODS 
 
3.1 Chemicals 
 All chemicals for media and buffers were purchased from Sigma-Aldrich (St. 
Oakville, ON) or DB-Canada (Oakville, ON) unless otherwise stated. All amino acids 
and antibiotics were purchased from Sigma-Aldrich. X-GAL (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside) and X-Gluc (5-bromo-4-chloro-3-indolyl-ß-D-
glucuronic acid) were purchased from Rose Scientific (Edmonton, AB).  
3.2 Bacteria and yeast cell methods 
3.2.1 Bacterial and yeast strains 
 For transformation and propagation of bacterial plasmids the E. coli strain 
DH12S (Ø80dlacZ∆M15 mcrA ∆[mrr-hsdRMS-mrcBC] araD139 ∆[ara, leu] 7697 
∆lacX74 galU galK rpsL deoR nupG recA 1/F’ proAB+ laclq Z∆M15) was purchased 
from Invitrogen (Burlington, ON).  
 All yeast methods used the Saccharomyces cerevisiae strain YPB2 (MATa, ura3-
52, his3-200, ade2-101, lys2-801, trp1-901, leu2-3, 112canR, Gal4-542, gal80-538, 
lys2::GalUAS-leu2TATA-his3, ura::GAL417 mer(x3), CYCTATA-LACZ; Bartel et al., 1993) 
obtained from Dr. W. Crosby (Plant Biotechnology Institute, Saskatoon, SK; currently in 
the Department of Biological Sciences, University of Windsor, Windsor, ON).  
 22
3.2.2 Bacterial media 
 Liquid and solid media (Table 3.1) were prepared and autoclaved before use. 
Appropriate antibiotics were added to media after autoclaving and cooling (for solid 
media), or immediately prior to use (liquid media). Stock solutions of all antibiotics 
(Table 3.2.) were stored at -20°C.  
 3.2.3 Yeast media 
 Synthetic dextrose (SD) medium was used for all experiments (Table 3.1). Drop-
out powder stocks contained all amino acids except those used for plasmid selection.  
3.2.4 Cell growth and storage conditions 
 All E. coli and yeast cell cultures were grown at 37°C and 30°C, respectively. 
Liquid cultures were shaken constantly at ~250 revolutions per minute (rpm). When 
required, cultures were temporarily stored at 4°C, or permanently stored at -80°C in 30% 
glycerol.   
3.2.5 Plasmid transformation into bacterial cells 
3.2.5.1 Preparation of electro-competent bacterial cells 
 Prewarmed 2YT medium, supplemented with 0.2% glucose was inoculated from 
an overnight preculture so that an OD600 (absorbance reading at 600 nm; measured with 
a Beckman model DU-65 spectrophotometer) of between 0.5 and 1.5 was reached after 2 
hours (hrs). Cells were harvested by centrifugation for 15 minutes (min), 2500 rpm at 
4°C with a GSA rotor (Sorvall, DuPont, Mississauga, ON). The resulting pellet was 
washed twice with an equal volume of ice-cold sterile water and once in 1/50th the 
volume of ice-cold sterile 10% glycerol before being resuspended in 1/100th the initial
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Table 3.1 Media used in this study. 
Culture  Typea  Componentsb
Bacteria 2YT 1.7% tryptone, 1% yeast extract, 0.5% NaCl 
Bacteria SOC 2% tryptone, 0.5% yeast extract, 8.5 mM NaCl, and 2.5 mM  
KCl, (10 mM MgCl2 and 200 mM glucose after autoclaving) 
Yeast SD 2% glucose, 0.67% yeast nitrogen base without amino acids,
0.15% of the appropriate dropout powderc
 
a Media was autoclaved at 20 psi (pounds per square inch) at 121°C for 30 min on the 
liquid cycle. 
b For bacteria and yeast solid media, 1.5% and 2 % agar was added respectively. 
c Prepared as per instructions (Kohalmi et al., 1997). 
 
 
 
 
Table 3.2 Antibiotics used in this study. 
Antibiotic Stock solutions* Final concentration in 
media 
Carbenicillin 50 mg/ml in water (filter sterilized) 12.5 mg/L 
Chloramphenicol 25 mg/ml in 100% ethanol 25 mg/L 
 
*Stock solutions stored at -20°C. 
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culture volume of cold sterile 10% glycerol. Aliquots of competent cells were stored at –
70°C until needed. 
3.2.5.2 Electroporation of electro-competent bacterial cells 
 A 50 µl volume of competent cells was added to an equal volume of water 
containing ~80 fmols plasmid DNA. The mixture was transferred to a chilled 0.2 cm gap 
electroporation cuvette (BTX®-Genetronics, San Diego, CA) ensuring no bubbles were 
created. The cells were electroporated using a Gene Pulsar (BioRad, Hercules, CA) set 
at:  
 Capacitance – 25 µFD 
 Resistance – 200 ohms 
 Volts – 2.5 Kvolts 
 The cells were then transferred to 1 ml of SOC medium and incubated at 37°C 
for 1 hr with shaking. Aliquots were plated on selective media to isolate transformants.   
3.2.6 Plasmid transformation into yeast cells 
3.2.6.1 Preparation of chemically competent yeast cells 
 SD +all medium was inoculated from an overnight preculture using the following 
formula: 
 Inoculation volume   =  desired cell density  x  culture volume      (3.1) 
                                        current cell density       2(# of generations) 
 
 where:  desired cell density is 0.6 OD600  
                       2 hrs is required to obtain each successive generation  
the current cell density was calculated by measuring the absorbance at 
OD600  
 
The cells were harvested by centrifugation for 5 min, 5000 rpm at room 
temperature with a GSA rotor (Sorvall). The cells were washed with 1/10th volume 
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sterile water, and resuspended with 1/100th the initial culture volume in lithium (Li) 
acetate solution (0.1 M Li Acetate, pH 7.5, in 1 x TE buffer, pH 7.5 [10 mM Tris, pH 
7.5, 1 mM ethylenediamine-tetracetic acid (EDTA), pH 7.5]), before being incubated for 
1 hr at 28°C with constant shaking. The now-competent cells were used for plasmid 
transformation or aliquoted and stored at –70°C until needed. 
3.2.6.2 Transformation of chemically competent yeast cells 
To 200 µl of competent yeast cells, 5 µg of plasmid DNA and 20 µl of sheared 
salmon sperm carrier DNA (10 mg·ml-1 stock solution) were added and incubated for 30 
mins at 28°C with shaking (Schiestl and Gietz, 1989). One point two millilitres of 
polyethylene glycol (PEG) solution (40% PEG 4000, 0.1 M Li acetate, pH 7.5, 1 x TE 
buffer, pH 7.5) was added, gently mixed, and the cells were returned to 28°C for 30 min. 
The cells were then heat-shocked at 42°C for 15 min, washed twice with 500 µl of 1 x 
TE buffer (pH 7.6) and plated on SD media lacking the appropriate amino acid(s). 
3.3 DNA methods 
3.3.1 Bacterial Plasmids 
 Plasmids pBCSK+ (Stratagene, La Jolla, CA), and pUCBM21 (Roche, Laval, 
QC) were used for general cloning. pBCSK+ contains the chloramphenicol 
acetyltransferase gene (cat) gene which provides resistance to the antibiotic 
chloramphenicol. pUCBM21 contains the β-lactamase (bla) gene which provides 
resistance to the antibiotic carbenicillin. 
 PCR fragments were cloned directly into the PCR®2.1-TOPO® (Invitrogen) 
plasmid which contains the neomycin phosphotransferase (npt) and bla genes which 
provide resistance to the antibiotics kanamycin and carbenicillin, respectively.   
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3.3.2 Yeast Plasmids 
 The yeast plasmids pBI771, pBI880 and pBI881 (Kohalmi et al., 1997) were 
obtained from Dr. W. Crosby. These vectors contain both the CEN6/ARS and ColE1 
origins of replication for propagation in yeast and E. coli respectively. All carry the bla 
gene, allowing for selection of bacteria cells in carbenicillin containing medium, and a 
yeast amino acid prototrophic marker, Leu2 in pBI880 and Trp1 in pBI771 and pBI881, 
allowing for selection of yeast cells in media lacking these amino acids. pBI880 contains 
the coding sequence for the GAL4 DB (DNA-binding) domain, while pBI771 and 
pBI881 contains the coding sequence for the GAL4 TA (transcription activation) 
domain. pBI771 and pBI881 differ only in the reading frame of the SalI restriction site 
in the multiple cloning region relative to the GAL4 DB coding region.  
A pBI771-derived plasmid (pFL759-1, referred to here as CaMV 35S:GUS), 
used for transactivation studies, contains the CaMV 35S promoter (starting at position –
343 from the transcriptional start site) fused to the β-glucuronidase (GUS) gene and 
nopaline synthase (nos) terminator (Jefferson et al., 1987; Stonehouse, 2002). This 
plasmid was used as a template to create another plasmid used for transactivation 
studies, rsL-20(5), referred to here as CaMV 35Smut:GUS, in which point mutations were 
introduced at each TGACG motif, changing them to TGCTG and TCTCG respectively 
(Stonehouse, 2002).  
3.3.3 Extraction of plasmid DNA from bacteria 
 The Qiagen® Plasmid Mini Kit (Qiagen, Mississauga, ON) or the QIAPrep® 8 
Turbo Miniprep Kit (Qiagen) was used according to manufacturer’s instructions to 
isolate plasmid DNA from bacteria.    
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3.3.4 Restriction enzyme digest 
 A typical reaction mixture consisted of 10 – 15 Units of each of the appropriate 
restriction enzymes, not exceeding 10% of the final reaction volume (New England 
BioLabs, Beverly, MA), 2.0 µl of the manufacturer recommended reaction buffer, 0.5 – 
5.0 µg of DNA, and sterile water to a final volume of 20 µl. The reaction mixture was 
incubated at 37°C for 2 hr before addition of 1.0 – 2.0 µl of stop/loading buffer (water, 
50% glycerol, 100 mM EDTA, 1% sodium dodedyl sulphate (SDS), 0.1% bromophenol 
blue) to stop the reaction. 
3.3.5 Agarose gel electrophoresis and recovery of DNA  
 Approximately 20 µl of restriction enzyme-digested or polymerase chain 
reaction (PCR) amplified DNA fragments (see sections 3.3.4 and 3.3.7) were loaded on 
a 0.8% agarose gel in 1x TAE buffer (12 mM Tris, 6 mM sodium acetate, 0.3 mM 
EDTA, pH 8.0), including 0.5 µg ml-1 ethidium bromide. The DNA fragments were 
separated at 90 V for about 20 – 30 min with a minisubTM DNA cell (BioRad) in 1x 
TAE buffer. The DNA was visualized using a GENE GENIUS Bio Imaging System 
(Syngene, Frederick, MD), the desired DNA bands were excised from the agarose and 
purified using the QiaexII Agarose Gel Extraction Protocol (Qiagen) as per 
manufacturer’s instructions. The resulting DNA was stored at -20°C if not used 
immediately. 
3.3.6 Ligation of DNA fragments into vector DNA 
 A typical ligation consisted of approximately 20 fmols of vector DNA, three 
times the molar amount (~60 fmols) of insert DNA, 1 Unit of the T4 DNA ligase 
enzyme (Invitrogen), 4 µl of 5x ligase buffer (Invitrogen), and water to a final volume of 
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20 µl. The ligation mixture was incubated overnight in a 12°C water bath. To minimize 
the salts that may interfere with the transformation, a desalting step of the ligation 
mixture was performed prior to electroporation. The ligation was diluted with 400 µl of 
sterile water and loaded onto a desalting ultrafree-MC column (Millipore, Bedford, 
MA), which was centrifuged at 8000 rpm for 10 min. The desalted DNA was eluted 
from the column with 20 µl of sterile water.   
PCR products were cloned into the pCR®2.1-TOPO® vector (Invitrogen) as per 
manufacturer’s instructions. 
3.3.7 PCR (Polymerase Chain Reaction) amplification  
 To confirm the presence of a plasmid in transformed bacterial cells a PCR was 
performed using aliquots of isolated colonies suspended in 50 µl of sterile water. A 
typical PCR amplification mixture consisted of 5 µl of cell suspension, 10 mmols of 2’-
deoxy-nucleotide 5’-triphosphates (Pfizer, New York, NY), 25 pmols of each 
oligonucleotide primer (synthesized by the DNA technology service at PBI/NRC), 1.25 
Units of Taq polymerase (Pfizer), 5 µl of 10x Taq reaction buffer (Pfizer), and water to a 
final reaction mixture volume of 50 µl.  
The PCR amplifications were performed using a PTC-200 Peltier Thermalcycler 
(MJ Research, Waltham, MA). An initial denaturing step was performed at 95°C for 5 
min. Each PCR consisted of 25 cycles containing a 1 min. denaturation step at 94°C, a 1 
min. annealing step at 55°C, and a 1 min. extension step at 72°C. At the end of the PCR 
amplification, the samples were incubated for 7 min at 72°C to ensure complete strand 
extension. 
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3.3.8 Introduction of point mutations  
3.3.8.1 Site-directed mutagenesis (SDM) 
Point mutations were introduced using QuikChangeTM Site-Directed Mutagenesis 
Kit (Stratagene) using mutagenic oligonucleotides listed in Table 3.3A and B.  
3.3.8.2 Stitching 
Stitching was utilized to simultaneously mutate two amino acids located within 
close proximity to each other in a gene (Sambrook and Russell, 2001). Three separate 
PCR reactions were performed to create an altered gene. Each PCR consisted of a single 
denaturing step at 94°C for 4 min. followed by 15 cycles each containing a 30 sec 
denaturation step at 94°C, a 30 sec. annealing step at 55°C, and a 30 sec. extension step 
at 72°C. The PCR amplification mixture consisted of 5-10 ng of DNA, 10 nmols of 2’-
deoxy-nucleotide 5’-triphosphates (Pfizer), 50 pmols of each oligonucleotide primer, 
1.25 Units of XTaq polymerase (Takara Mirus Bio. Inc., Madison, WI), 5 µl of 10x Taq 
reaction buffer, and water to a final reaction mixture volume of 50 µl.  
Four oligos were needed to complete the procedure: 5’ and 3’ oligonucleotides 
located in the vector upstream and downstream of the start and stop codons respectively 
(5’-vector, 3’-vector); as well as 5’ and 3’ gene specific oligonucleotides that span the 
site of the desired mutations (5’-mut, 3’-mut; Table 3.3C). The gene specific 
oligonucleotides include the desired mutations and contain ~70% overlap to each other. 
The initial two PCR reactions, performed concurrently, used a plasmid containing the 
wild type coding sequence of the gene as template DNA. The first reaction used the 5’-
vector and 3’-mut oligonucleotides to amplify the 5’ end of the gene to the desired 
mutations. The second reaction used the 5’-mut and 3’-vector
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 Table 3.3 Oligonucleotides used for PCR amplification and sequencing.  
Primer Name 5’ to 3’ sequence Primer 
Target 
Purpose 
A. Oligos previously designed 
TGA1 P1 GCGTCGACCATGAACTCGAC
ATCGACACATTTTGTG 
TGA1 Cloning, adds Sal1 site prior 
to start codon. 
TGA1 P2 ATGCGGCCGCTACGTTGGTTC
ACGATGTCG 
TGA1 Cloning, adds Not1 site 
subsequent to stop codon. 
TGA2 P1 GCGTCGACTATGGCTGATAC
CAGTCCGAGAAC 
TGA2 Cloning, adds Sal1 site prior 
to start codon. 
TGA2 P4 ATGCGGCCGCTCACTCTCTGG
GTCGAGCAAGCC 
TGA2 Cloning, adds Not1 site 
subsequent to stop codon. 
BC293 GAATAAGTGCGACATCATC pBI880 Vector specific sequencing 
primer. 
BC304 CTATTCGATGATGAAGATAC
C 
pBI881 Vector specific sequencing 
primer. 
JN069 TTGATTGGAGACTTGACC pBI880/881 Vector specific reverse 
sequencing primer. 
UP CCCAGTCACGACGTTGTAAA
ACG 
 Universal sequencing 
primer. 
RP AGCGGATAACAATTTCACAC
AGG 
 Reverse sequencing primer. 
B. Oligos designed for SDM 
TGA1-M1 GGGTTGAAGAACAGAACAGA
CAGATATCCTGAACTAAGAA
CAG 
TGA1 Changes Cys172 to Ser172 
TGA1-M2 CTGTTCTTAGTTCAGATATCT
GTCTGTTCTGTTCTTCAACCC 
TGA1 Changes Cys172 to Ser172 
TGA1 S-P1 GCAATCTAAAACAATCGTCG
CCAGCAAGCAGAAGACGCGT
TG 
TGA1 Changes Cys266 to Ser266 
TGA1 S-P2 CAACGCGTCTTCTGCTTGCTG
CGACGATTGTTTTAGATTGC 
TGA1 Changes Cys266 to Ser266 
TGA1 N-P1  CTTCTAGATGTAAACAATCTA
AAACAATCGTGTCAGCAAGC
AGAAGACGCG 
TGA1 Changes Cys260 to Asn260 
TGA1 N-P2 CGCGTCTTCTGCTTGCTGACA
CGATTGTTTTAGATTGTTTAC
ATC 
TGA1 Changes Cys260 to Asn260 
TGA1 S (1C)-P1 CTTCTAGATGTATCCAATCTA
AAACAATCGTGTCAGCAAGC
AGAAGACGCG 
TGA1 Changes Cys260 to Ser260 
TGA1 S (1C)-P2 CGCGTCTTCTGCTTGCTGACA
CGATTGTTTTAGATTCGATAC
ATCTAGAAG 
TGA1 Changes Cys260 to Ser260 
TGA1 ADS-P1 CACACCCTTGCGGACTCCGTT
GCAGCGGGACAA 
TGA1 Changes Cys287 to Ser287 
TGA1 ADS-P2 TTGTCCCGCTGCAACGGAGT
CCGCAAGGGTGTG 
TGA1 Changes Cys287 to Ser287 
TGA2 FC-1 GGAAAACACCAGCTGAGAGA
TTCTTCTTGTGGCTCGGTGG 
TGA2 Changes Cys186 to Phe186 
TGA2 FC-2 CCACCGAGCCACAAGAAGAA
TCTCTCAGCTGGTGTTTTCC 
TGA2 Changes Cys186 to Phe186 
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Table 3.3 Oligonucleotides used for PCR amplification and sequencing continued.  
 
Primer Name 5’ to 3’ sequence Primer 
Target 
Purpose 
B. Oligos designed for SDM (continued) 
TGA2 NC-1 CAGTTGATGGGCATATGTAA
CCTGCACAGACATCGCAGC 
TGA2 Changes Asn218 to Cys218 
TGA2 NC-2 GCTGCGATGTCTGTTGCAGGT
TACATATGCCCATCAACTG 
TGA2 Changes Asn218 to Cys218 
TGA2 SC-1 CCTGCAACAGACATGCCAGC
AGGCTGAAGATGCTTTGTCTC
AAGG 
TGA2 Changes Ser224 to Cys224 
TGA2 SC-2 CCTTGAGACAAAGCATCTTC
AGCCTGCTGGCATGTCTGTTG
CAGG 
TGA2 Changes Ser224 to Cys224 
TGA2 C130-M1 GAAAAGAACAAGCAAATGTG
CGAGCTGAGGTCTGCTCTG 
TGA2 Changes Asn130 to Cys130 
TGA2 C130-M2 CAGAGCAGACCTCAGCTCGC
ACATTTGCTTGTTCTTTTC 
TGA2 Changes Asn130 to Cys130 
TGA4 S3 CGGATCAACAACTTTTGGAT
GTATCCAATCTGAGGCAATC
ATGTCAACAAGC 
TGA4 Changes Cys256 to Ser256 
TGA4 S4 GCTTGTTGACATGATTGCCTC
AGATTGGATACATCCAAAAG
TTGT 
TGA4 Changes Cys256 to Ser256 
TGA4 S5 CCAATCTGAGGCAATCATCC
CAACAAGCAGAAGATGCG 
TGA4 Changes Cys256 and 
Cys262 to Ser256 and 
Ser262 
TGA4 S6 CGCATCTTCTGCTTGTTGGGA
TGATTGCCTCAGATTGG 
TGA4 Changes Cys256 and 
Cys262 to Ser256 and 
Ser262 
C. Oligos designed for stitching 
TGA1 NS-P1 GATGTAAACAATCTAAAACA
ATCGTCTCAGCAAGCAGAAG
ACGCG 
TGA1 Changes Cys260 and 
Cys266 to Asn260 and 
Ser266 
TGA1 NS-P2 CTGAGACGATTGTTTTAGATT
GTTTACATCTAGAAGTTGTTG 
TGA1 Changes Cys260 and 
Cys266 to Asn260 and 
Ser266 
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oligonucleotides to amplify from the desired mutations to the 3’ end of the gene. Each 
PCR reaction was subjected to agarose gel electrophoresis, the desired DNA bands were 
excised and purified using the QiaexII Agarose Gel Extraction Protocol (Qiagen) as per 
manufacturer’s instructions. The final PCR used the two gel-purified fragments of the 
gene as template DNA and the 5’-vector and 3’-vector oligonucleotides to ‘stitch’ the 
complete gene together, including the newly introduced mutations.  
3.4 Plasmid construction 
The constructs desired for this study included point mutations within TGA1 or 
TGA2, chimeric genes including the coding region from these genes, and the chimeric 
genes with point mutations. Dr. Charles Després previously constructed all of the 
chimeric genes through stitching. Plasmids containing the full length coding region of 
TGA1, TGA2, or the chimeric genes, site mutations were introduced through site-
directed mutagenesis or stitching as described above. The resulting plasmid DNA was 
purified and assessed for the presence of desired mutations by sequence analysis. 
Sequencing was performed by the DNA Technologies Unit at PBI/NRC and analyzed 
using LaserGene (DNAstarTM, Madison, WI) Mapdraw program.   
In every case, a Sal1 restriction site directly before the start codon, and a Not1 
restriction site directly after the stop codon flanked the full-length coding region of the 
genes. Using these restriction enzyme sites the coding regions were transferred from the 
cloning vectors into the appropriate yeast plasmids and the integrity of the resulting 
GAL4 fusion was confirmed by sequence analysis. 
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3.5 Enzymatic assays 
3.5.1 β-galactosidase assay 
To display β-galactosidase activity, three isolated colonies of each 
transformation experiment were transferred to a fresh plate and grown overnight at 
28°C. The colonies were lifted from the plate using a 0.45 micron nylon transfer 
membrane (GE Osmonics, Trevose, PA), which was then submerged in liquid nitrogen 
for 5-10 seconds to lyse the cells. The thawed membrane was laid on a piece of 
Whatman #1 filter paper saturated with Z-buffer (100 mM Na2PO4, 10 mM KCl, 1 mM 
MgSO4, 0.27% β-mercaptoethanol and 0.024 mM X-GAL), and incubated at 28°C 
overnight (Kohalmi et al., 1997). 
3.5.2 Quantitative β-glucuronidase (GUS) assay of yeast cells 
 An overnight preculture was used to inoculate a fresh culture so that the OD600 
was 0.5-0.8 after 2-3 hrs incubation at 28°C. A 1.9 ml aliquot of cell suspension was 
pelleted in a microcentrifuge and 200 µl of GUS extraction buffer (50 mM NaPO4, pH 
7.0, 10 mM Na2EDTA, pH 8.0, 10 mM β-mercaptoethanol, 0.1% Sarcosyl, 0.1% 
Triton X-100) and 100 µl volume of 425-600 micron, acid-washed glass beads (Sigma, 
G-8772) was added to the pellet. The cells were lysed by seven repetitions of vortexing 
for 30 sec. and cooling on ice for 30 sec., and cell debris was removed by centrifugation. 
At this point the cell extract was used for GUS analysis or frozen at -80°C for future use. 
 To 450 µl of 1 mM methyl-umbelliferyl-β-D-glucuronide (MUG) solution, 50 µl 
of cell extract was added, followed by incubation at 37°C. At various time points (0, 1, 
2, and 3 hrs) 100 µl aliquots were taken and mixed with 900 µl of 0.2 M Na2CO3 stop 
buffer. GUS activity was determined by measuring methyl-umbelliferone (MU) 
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fluorescence by a Perkin Elmer LS50 Luminescence Spectrometer (Wellesley, MA) 
using an excitation wavelength of 365 nm and an emission wavelength of 455 nm. The 
luminescence spectrometer was calibrated with 100 nM and 1 µM MU standards made 
in 0.2 M Na2CO3 stop buffer.  
3.5.3 Quantitative protein assay 
 To standardize the results observed in the GUS quantitative assay, 20 µl of the 
cell extract was used to quantify the total protein level using the Microassay Procedure 
of the BioRad Protein assay as instructed by the manufacturer. Protein levels were 
correlated to a standard curve composed from measuring six bovine albumin (BSA) 
standards ranging from 2 µg/ml to 20 µg/ml.  
 The results of the GUS and protein quantitative assays were combined to 
determine a value that standardized the amount of GUS activity in µM of MU per µg of 
protein per minute (µM MU·µg protein-1·min-1).  
3.5.4 Statistical analysis of quantified GUS activity 
 To test whether the differences in GUS activity observed between yeast cells 
with different effector and reporter plasmids were significantly different, a Student’s t-
test was performed. The formulas used to derive the observed tvalue were: 
 Standard Deviation2 (Sd2) =  (n1-1)S12 + (n2-1)S22                                         (3.2) 
                  n1 + n2 – 2  
 
 tvalue =                      ± X1 – X2                                                  (3.3) 
     Sd [sqrt (1/n1 + 1/n2)]  
 
Where: n1 and n2 are the sample sizes of the two groups respectively 
 S1 and S2 are the standard deviations of the two sample groups  
 X1 and X2 are the mean GUS activities of the two sample groups 
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 Sd is the modified standard deviation that incorporates size and  
  standard deviations of both of the sample groups. 
 
In this study, the 10 degrees of freedom and a 95% confidence level (p = 0.05) was used 
to determine if the activity observed in the yeast cells was significantly different.  
 
 36
CHAPTER 4: RESULTS 
 
4.1 Role of cysteine residues in controlling transactivation by TGA1/TGA4 and the 
interaction of TGA factors with NPR1 
4.1.1 Role of TGA1 cysteines within the 30 amino acid domain 
Previous research identified a 30 amino acid region of TGA2 that, when used to 
replace the corresponding sequences from TGA1, enabled the resulting chimeric protein 
to interact with NPR1 while abolishing transactivation in yeast (Després et al., 2003; see 
also Figure 4.1 and section 2.6.1). To identify the residues within the 30 amino acid 
region that are important for these functions, a rational site-directed mutagenesis 
approach was taken based on a multiple alignment of seven Arabidopsis TGA factors 
between the region corresponding to amino acids 236 to 266 of TGA1 (Figure 4.2). The 
selection criteria for targeting an amino acid were that the residue needed to be 
conserved between TGA1 and TGA4 but had to differ from that of the conserved 
residues in the remaining TGA factors analyzed. Cysteine 266 (Cys-266) is the only 
residue that conforms to these criteria (Figure 4.2). It is conserved between TGA1 and 
TGA4, while in all other TGA factors a conserved serine (Ser) residue is present at the 
corresponding position. Since Cys residues possess the unique ability to form a bond 
between their sulfhydryl side chains, called a disulfide bond, the other Cys residue found 
within the 30 amino acid region, at residue 260 (Cys-260), was also targeted for 
mutagenesis. Cys-260 conforms to the first criterion as it is conserved between TGA1
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Figure 4.1 Transactivation and NPR1-interaction properties of TGA1 containing 
mutations within the 30 amino acid region. 
β-galactosidase assays were performed on yeast cells transformed with TGA constructs 
fused to the domains indicated. Labels at top indicate the property tested. Each spot 
represents an independent transformation event. A blue colour observed with GAL4:DB 
fusions to TGA factors indicates autonomous transactivation of the construct. Blue 
colour observed with GAL4:TA fusions of TGA factors in cells also containing 
DB:NPR1 indicates interaction between the test protein pair. 
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M-----NSTSTHFVPPRRVGIYEPVHQFGMWGE-----SFKSNISNGTMNTPNHII--IPNNQKLDNNVSED----TSHGTAGTPHMFDQEASTSRHPDK 84 TGA1
M-----NTTSTHFVPPRRFEVYEPLNQIGMWEE-----SFKNN---GDMYTPGSII--IPTNEK-PDSLSED----TSHGTEGTPHKFDQEASTSRHPDK 80 TGA4
MA------------------------------------------------------DTSPRTDVSTDDDTDHPDLGSEGALVNTAASDSSDRSKGKMDQK 46 TGA2
MH------------------------------------------------------SLN--ETVIPDVDYMQSDRGH----MHAAASDSSDRSKDKLDQK 40 TGA6
------------------------------------------------------------RTSVSTDGDTDHNNLMFDEGHLGIGASDSSDRSKSKMDQK 40 TGA5
MEMMSSSSSTTQVVSFRDMGMYEPFQQLSGWESPFKSDINNITSNQNNNQSSSTTLEVDARPEADDNN-RVNYTSVYNNSLEAEPSSNNDQDED-RINDK 98 TGA3
MM---SSSSPTQLASLRDMGIYEPFQQIVGWGNVFKSDIND----HSPNTATSSIIQVDPRIDDHNNNIKINYDSSHNQIEAEQPSSNDNQDDDGRIHDK 93 TGA7
IQRRLAQNREAARKSRLRKKAYVQQLETSRLKLIQLEQELDRARQQGFYVGNGIDTNSLGFSETMNPGIAAFEMEYGHWVEEQNRQICELRTVLHGHIND 184 TGA1
IQRRLAQNREAARKSRLRKKAYVQQLETSRLKLIHLEQELDRARQQGFYVGNGVDTNALSFSDNMSSGIVAFEMEYGHWVEEQNRQICELRTVLHGQVSD 180 TGA4
TLRRLAQNREAARKSRLRKKAYVQQLENSRLKLTQLEQELQRARQQGVFISGTGDQAH---STGGNG-ALAFDAEHSRWLEEKNKQMNELRSALNAHAGD 142 TGA2
TLRRLAQNREAARKSRLRKKAYVQQLEDSRLKLTQVEQELQRARQQGVFISSSGDQAH---STGGNGGALAFDAEHSRWLEEKNRQMNELRSALNAHAGD 137 TGA6
TLRRLAQNREAARKSRLRKKAYVQQLENSRLKLTQLEQELQRARQQGVFISSSGDQAH---STAGDG-AMAFDVEYRRWQEDKNRQMKELSSAIDSHATD 136 TGA5
MKRRLAQNREAARKSRLRKKAHVQQLEESRLKLSQLEQELVRARQQGLCVRNSSDTSYLGPAGNMNSGIAAFEMEYTHWLEEQNRRVSEIRTALQAHIGD 198 TGA3
MKRRLAQNREAARKSRLRKKAYVQQLEESRLKLSQLEQELEKVKQQG----------HLGPSGSINTGIASFEMEYSHWLQEQSRRVSELRTALQSHISD 183 TGA7
IELRSLVENAMKHYFELFRMKSSAAKADVFFVMSGMWRTSAERFFLWIGGFRPSDLLKVLLPHFDVLTDQQLLDVCNLKQSCQQAEDALTQGMEKLQHTL 284 TGA1
IELRSLVENAMKHYFQLFRMKSAAAKIDVFYVMSGMWKTSAERFFLWIGGFRPSELLKVLLPHFDPLTDQQLLDVCNLRQSCQQSEDALSQGMEKLQHTL 280 TGA4
SELRIIVDGVMAHYEELFRIKSNAAKNDVFHLLSGMWKTPAERCFLWLGGFRSSELLKLLANQLEPMTERQLMGINNLQQTSQQAEDALSQGMESLQQSL 242 TGA2
TELRIIVDGVMAHYEELFRIKSNASKNDVFHLLSGMWKTPAERCFLWLGGFPSSELLKLLANQLEPMTERQVMGINSLQQTSQQAEDALSQGMESLQQSL 237 TGA6
SELRIIVDGVIAHYEELYRIKGNAAKSDVFHLLSGMWKTPAERCFLWLGGFRSSELLKLIACQLEPLTEQQSLDINNLQQSTQQAEDALSQGMDNLQQSL 236 TGA5
IELKMLVDSCLNHYANLFRMKADAAKADVFFLMSGMWRTSTERFFQWIGGFRPSELLNVVMPYVEPLTDQQLLEVRNLQQSSQQAEEALSQGLDKLQQGL 298 TGA3
IELKMLVESCLNHYANLFQMKSDAAKADVFYLISGMWRTSTERFFQWIGGFRPSELLNVVMPYLQPLTDQQILEVRNLQQSSQQAEDALSQGIDKLQQSL 283 TGA7
-RTVAAGQ--LGEGS----YIPQVNSAMDRLEALVSFVNQADHLRHETLQQMYRILTTRQAARGLLALGEYFQRLRALSSSWATRHREPT           367 TGA1
AESVAAGK--LGEGS----YIPQMTCAMERLEALVSFVNQADHLRHETLQQMHRILTTRQAARGLLALGEYFQRLRALSSSWAARQREPT           364 TGA4
ADTLSSGTLGSSSSGNVASYMGQMAMAMGKLGTLEGFIRQADNLRLQTLQQMIRVLTTRQSARALLAIHDYFSRLRALSSLWLARPRE             330 TGA2
ADTLSSGTLGSSSSDNVASYMGQMAMAMGKLGTLEGFIRQADNLRLQTLQQMLRVLTTRQSARALLAIHDYSSRLRALSSLWLARPRE             325 TGA6
ADTLSSGTLGSSSSGNVASYMGQMAMAMGKLGTLEGFIRQADNLRLQTYQQMVRLLTTRQSARALLAVHNYTLRLRALSSLWLARPRE             324 TGA5
VESIAIQIKVVESVN----HGAPMASAMENLQALESFVNQADHLRQQTLQQMSKILTTRQAARGLLALGEYFHRLRALSSLWAARPRE--H          383 TGA3
AESIVIDA-VIESTH----YPTHMAAAIENLQALEGFVNQADHLRQQTLQQMAKILTTRQSARGLLALGEYLHRLRALSSLWAARPQEPT.          369 TGA7
ADC
S
 
 
Figure 4.2 Alignment of seven of the Arabidopsis TGA factors. 
Dashed and solid blue lines indicate the basic and leucine zipper domains respectively. 
The dark purple box indicates cysteines of TGA1 and TGA4 at positions 172 and 168 
respectively. The blue/green closed box indicates cysteine of TGA2 at position 186. The 
green closed box indicates residues or TGA1, TGA4, and TGA2 at positions 260, 256, 
and 218 respectively. The orange closed box indicates residues of TGA1, TGA4, and 
TGA2 at positions 266, 262, and 224 respectively. The yellow closed boxes indicate 
residues of TGA1 and TGA2 at positions 287 and 245 respectively. The light purple 
closed box and solid lines indicate regions used to mark changes for chimeric proteins. 
The red open box indicates the 30 amino acid span between position 236 and 266 of 
TGA1 that was replaced with the corresponding region from TGA2. Dashes indicate 
gaps introduced to facilitate proper alignment. 
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and TGA4, but the residue is not strictly conserved in the remaining TGA factors 
(Figure 4.2).  
The complete coding region of TGA1 in pBC-SK+ was used as a substrate for 
site-directed mutagenesis (SDM). The first mutant gene created encodes a full-length 
protein in which Cys-260 and Cys-266 were replaced with asparagine (Asn) and Ser, the 
corresponding residues from TGA2, respectively (TGA1C260N,C266S; Figure 4.3). The 
mutant gene was subsequently ligated into pBI880 and pBI881 (Kohalmi et al., 1997) to 
generate N-terminal fusions to the GAL4 DNA binding and GAL4 transactivation 
domains, respectively. The resulting GAL4 TA fusion protein was co-expressed in yeast 
with DB:NPR1 and the interaction between proteins was assessed using β-galactosidase 
assays. If the test proteins interact, the GAL4 TA domain is brought in close proximity 
to the GAL4UAS in the promoter of the β-galactosidase gene (LacZ) and initiates 
transcription, resulting in a blue colour when cells are treated with the colorimetric 
substrate X-GAL (Kohalmi et al., 1997). This assay revealed that TA:TGA1 and 
DB:NPR1 do not interact (Figure 4.1), while TA:TGA1C260N,C266S and DB:NPR1 do 
interact (Figure 4.3). 
The mutant GAL4 DB fusion protein (DB:TGA1C260N,C266S) was assessed for 
transactivation abilities using the β-galactosidase assay by coexpression with 
TA:cruciferin (TA:Cruc). Cruciferin is a seed storage protein that does not interact with 
TGA factors (Stonehouse, 2002). Therefore the GAL4 TA domain is not recruited to the 
GAL4UAS and is unable to transactivate the LacZ gene. Consequently, any blue colour 
formed during the β-galactosidase assay is due solely to the autonomous transactivation 
capabilities of the TGA factor. Results of this test indicate that the DB:TGA1C260N,C266S 
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Figure 4.3 β-galactosidase assay results for TGA1 and TGA4 site-directed mutants used 
in this study. 
Schematic representation of TGA1 (orange), TGA2 (blue), TGA4 (green) constructs 
showing the bZip domain of each (lighter shade) and location of point mutations 
(coloured bars). β-galactosidase assay results for transactivation and NPR1 interaction 
indicated by – (white), +/- (faint blue), and + (blue) after 24 hours. The +/- symbol is 
used to indicate when the blue colour observed was considerably less than the positive 
control (interaction between NPR1 and TGA2). Transactivation results were obtained 
from mutant constructs fused to the GAL4 DB domain in yeast cells coexpressing 
cruciferin fused to the GAL4 TA domain. NPR1 interaction results were obtained from 
mutant constructs fused to the GAL4 TA domain in yeast cells coexpressing NPR1 fused 
to the GAL4 DB domain. Drawings are not to scale. 
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construct was able to transactivate weakly (Figure 4.3). The above results indicate that 
the Cys residues within the 30 amino acid region of TGA1 are important for its ability to 
interact with NPR1.  
To resolve the role of the individual Cys residues, Cys-260 and Cys-266 were 
mutated independently and yeast cells were transformed with the resulting genes in 
pBI880 or pBI881. Results shown in Figure 4.1 and summarized in Figure 4.3 indicate 
that TA:TGA1C260N interacts with DB:NPR1 while the DB:TGA1C260N construct 
transactivated weakly. In contrast, TA:TGA1C266S interacts poorly with DB:NPR1 while 
DB:TGA1C266S transactivates (Figure 4.1; 4.3). Cys-260 was also changed to a serine 
(TGA1C260S), a structurally similar amino acid, and tested for NPR1 interaction and 
transactivation (Figure 4.3). TA:TGA1C260S interacts with NPR1 while the same mutant 
fused to GAL4:DB (DB:TGA1C260S) transactivates weakly (Figure 4.3). Although the 
above results are not quantitative, they clearly indicate that modifying Cys-260 has more 
significant consequences on TGA1 properties than modifying Cys-266, suggesting a 
more prominent role for the former amino acid in controlling the TGA1 functions tested. 
4.1.1.1 Quantitative analysis of transactivation for TGA1 mutants with altered 
cysteines within the 30 amino acid region 
β-galactosidase assays possess the limiting factor that they are restrictive to a 
qualitative, or at best semi-quantitative, observation based on the presence and intensity 
of the blue product. Also, testing of GAL4 DB fusions with the GAL4UAS promoter 
element may not accurately reflect the ability of mutated proteins to interact with their 
cognate promoter binding sites. To help resolve these problems, quantitative 
experiments were performed using a GUS (uidA) reporter gene under the control of one 
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of the best characterized targets of the TGA factors, the CaMV 35S as-1 element (Lam 
et al., 1989), which has been previously shown to be active in yeast (Rüth et al., 1992). 
DB:TGA1, DB:TGA2, and GAL4DB fusions to different TGA1 SDM constructs 
were transformed into yeast cells harbouring a pBI881 derivative containing the CaMV 
35S:GUS gene (pFL759-1; Stonehouse et al., 2002). In these assays, the TGA factors 
should interact with the CaMV 35S promoter through the as-1 element (see results 
below from control experiments with the CaMV 35S promoter containing a mutant as-1 
element). If the factor possesses transactivational properties the GUS gene will be 
expressed and the activity of the resulting enzyme can be quantified by measuring 
fluorescence of the 4-methyl umbelliferone (MU) product after the addition of the 4-
methyl umbelliferyl glucuronide (MUG) substrate (Jefferson, 1987).  
Background levels of GUS activity in the yeast cells, assessed by measuring MU 
levels in cells containing a DB:Cruc fusion along with the CaMV 35S:GUS reporter 
construct, averaged 2.82 pM MU/µg protein/min (Figure 4.4). Cells containing 
DB:TGA1 and the CaMV 35S:GUS plasmid displayed the highest levels of GUS 
activity measured in this study, averaging 32.21 pM MU/µg protein/min. A Student’s t-
test at a 95% confidence level (p = 0.05), indicates that GUS activity in these cells is 
significantly different from background levels. This result is consistent with β-
galactosidase assays where DB:TGA1 transactivated (Figure 4.1). Levels of GUS 
activity measured in cells containing the DB:TGA2 were lower than those observed in 
cells containing DB:Cruc /CaMV 35S:GUS (averaging 0.23 pM MU/µg protein/min). A 
Student’s t-test (p = 0.05) revealed that this difference is statistically significant, which 
suggests that TGA2 may be repressing transactivation.  
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Figure 4.4 Quantitative GUS assay of transactivation of TGA1 with mutation of the 
cysteine residues. 
Transactivation levels of TGA constructs and cruciferin when measured using 
the wild type CaMV 35S promoter and a mutated version of the promoter. Each bar 
represents the average of six independent GUS assays from a total of two independent 
transformations ± SE.  
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To ensure that GUS activity observed in cells containing DB:TGA1 is attributed 
to binding of the as-1 element, this GAL4 DB fusion was tested against a CaMV 
35S:GUS reporter gene with a mutant as-1 element (pRSL20(5), hereafter referred to as 
CaMV 35Smut:GUS) (Stonehouse, 2002). This mutant element possesses point mutations 
at each TGACG motif, changing them to TGCTG and TCTCG, respectively 
(Stonehouse, 2002). TGA factors are unable to bind to this mutant as-1 element 
(Després et al., 2000; Rüth et al., 1992). The levels of GUS activity measured in cells 
containing CaMV 35Smut:GUS with either DB:TGA1 or DB:Cruc, or containing 
DB:Cruc and CaMV 35S:GUS were not statistically different from the background 
fluorescence (Figure 4.4), indicating that TGA1 is unable to bind to the mutant as-1 
element.  
When tested in combination with CaMV 35S:GUS, DB:TGA1C260N and 
DB:TGA1C260N,C266S displayed the greatest reduction in transactivation properties 
relative to DB:TGA1, dropping to an average of 11.32 pM MU/µg protein/min and 
12.78 pM MU/µg protein/min, respectively (Figure 4.4). Using the Student’s t-test (p = 
0.05) these numbers were not found to be significantly different from each other but are 
significantly different than values obtained with DB:TGA1. Transactivation levels of the 
DB:TGA1C266S construct (averaging 23.8 pM MU/µg protein/min) were also 
significantly reduced (p = 0.05) relative to wild type DB:TGA1 supporting a role for 
Cys-266 in transactivation. However, GUS activity levels in cells expressing 
DB:TGA1C266S are still significantly greater than those observed with TGA1C260N. These 
results are consistent with the β-galactosidase assays showing that the mutation of Cys-
260 affects the properties of TGA1 to a greater extent than the mutation of Cys-266 and 
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further indicates that Cys-260 plays a critical role in mediating TGA1 transactivation. It 
may be important to note that although transactivation is reduced in cells containing the 
mutant TGA factors it is not entirely abolished to background levels. This suggests that 
additional amino acids or regions of TGA1 are involved in transactivation. 
4.1.2 Role of TGA4 cysteines within the 30 amino acid region  
TGA4 possesses 83.8% similarity to TGA1 at the amino acid level, the highest 
degree of similarity to TGA1 among the seven Arabidopsis TGA factors (Figure 4.2). In 
particular, TGA4 is the only other TGA factor with cysteines at positions corresponding 
to Cys-260 and Cys-266 of TGA1 (Figure 4.2). Furthermore both transactivate but do 
not interact with NPR1 in yeast. Given these similarities, both proteins may be regulated 
in a similar fashion; accordingly I decided to extend my survey of the effects of Cys 
residues within the 30 amino acid region to include TGA4.  
Using an approach similar to the one utilized with TGA1, a mutant gene was 
created which encodes a full-length protein with Ser residues instead of cysteines at 
positions 256 and 262 (TGA4C256S,C262S; Figure 4.3). The altered Cys residues 
correspond to Cys-260 and 266 of TGA1 (Figure 4.2). The mutant gene was ligated into 
pBI880 and pBI881 and introduced into yeast cells along with plasmids encoding 
TA:Cruc and DB:NPR1, respectively. Results from cells co-expressing 
TA:TGA4C256S,C262S and DB:NPR1 confirmed that they do interact and are therefore 
similar to those obtained with TGA1C260N,C266S in this respect (Figure 4.2). Furthermore 
DB:TGA4C256S,C262S is also similar to DB:TGA1C260N,C266S in that it transactivated 
weakly (Figure 4.2). 
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The codon for Cys at position 256 of TGA4 was also changed to encode a Ser 
and the resulting gene was introduced into pBI880 and pBI881. The β-galactosidase 
assays revealed that TA:TGA4C256S interacts weakly with DB:NPR1 while 
DB:TGA4C256S transactivated weakly. Together these results suggest that the Cys-256 
contributes substantially to the properties seen in TGA4. A TGA4C262S mutant has not 
been created or tested. Although the Cys residues within the 30 amino acid region of 
TGA4 do affect the protein’s properties, the change in properties observed in these 
mutants is not identical to the change observed in the TGA1 mutants. These differences 
may be resolved when a complete analysis of the remaining two Cys residues is 
accomplished; however the results thus far do indicate that a slight difference in the 
mode of regulation may exist between TGA1 and TGA4.  
4.1.3 Role of TGA1 cysteines outside of the 30 amino acid domain 
Disulfide bonds may occur between cysteines located in the same protein 
(intramolecular) or between different proteins (intermolecular), causing conformational 
changes of the protein (see for example, Delaunay et al., 2002; Mahoney et al., 1996). 
Accordingly, it is tempting to speculate that Cys-260 of TGA1 may participate in 
forming such a bond. The mutation to Ser or Asn would preclude the formation of this 
bond, causing a conformation change of TGA1, hence affecting its ability to 
transactivate and interact with NPR1. In support of this hypothesis, the electrophoretic 
mobility of in vitro-produced TGA1, but not TGA1C260S, has recently been shown to 
change under different redox conditions, suggesting TGA1 may contain an 
intramolecular disulfide bond (Després et al., 2003). As only one of the Cys residues 
within the 30 amino acid region (Cys-260) profoundly affects TGA1 properties, analysis 
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of the Cys residues outside of the 30 amino acid domain was undertaken to identify its 
potential partner in the intramolecular disulfide bond.  
Two cysteines are present outside of the 30 amino acid region of TGA1 at 
residues 172 and 287 (Figure 4.2). The codons for these residues were respectively 
mutated to encode for Asn and Ser, the corresponding residues from TGA2. The 
resulting genes were ligated into pBI880 and pBI881 and introduced into yeast cells. β-
galactosidase assays revealed that TGA1C172N interacts weakly with NPR1 while it is 
still able to transactivate (Figure 4.3). In addition to mutating Cys-172 to Asn, it was 
also changed to a Ser, the corresponding residue from TGA3 and TGA7 (Figure 4.2). 
This mutant produced results identical to those with TGA1C172N in that it was capable of 
both transactivation and interaction with NPR1 (Figure 4.3). These results show that 
Cys-172 influences the ability of TGA1 to interact with NPR1, but not its transactivation 
properties.  
Mutation of Cys287 to Ser resulted in a protein that still transactivated and was 
unable to interact with NPR1 (Figure 4.3). Therefore, TGA1C287S behaves the same as 
wild type TGA1, indicating that Cys-287 does not play a critical role in regulating 
transactivation or interaction with NPR1 in yeast. Together, results with Cys residues 
outside of the 30 amino acid domain suggest that Cys-172 is more likely than Cys-287 at 
partnering with Cys-260 to form an intramolecular disulfide bond.  
4.1.3.1 Quantitative analysis of transactivation of TGA1 mutants in cysteines 
outside the 30 amino acid region 
The results for transactivation obtained above by the qualitative β-galactosidase 
assay were quantified using the CaMV 35S:GUS reporter gene. The DB:TGA1C287S 
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construct showed a slight decrease in transactivation levels, averaging 27.95 pM 
MU/µg of protein/min, compared to DB:TGA1 (Figure 4.4). However, a Student’s t-
test (p = 0.05) indicates that this difference in GUS activity is not significantly 
different.  
The DB:TGA1C172N construct showed a decrease in transactivation levels to an 
average of 21.68 pM MU/µg of protein/min compared to the DB:TGA1 (Figure 4.4). 
The transactivation levels of DB:TGA1C172N is significantly lower than DB:TGA1 
according to the Student’s t-test (p=0.05). This value is not significantly different to 
that obtained with DB:TGA1C266S (p=0.05). 
4.1.4 Simultaneous mutation of multiple cysteines in TGA1 
 Although Cys-260 appears to make the more substantial contributions to TGA1’s 
properties, a possible role for the other Cys residues cannot be entirely ignored based 
solely on the analysis of proteins with mutations at single Cys residues. To further probe 
the potential roles each residue and identify possible interactions between the four Cys 
residues, mutant genes were created that encode proteins containing two or more 
mutated Cys residues (Figure 4.3). As previously described for the single mutants, the 
complete coding region of TGA1 in pBC-SK+ served as a template for creating genes 
with multiple mutations (see section 3.3.8), which were subsequently ligated into 
pBI880 and pBI881 and introduced into yeast cells. 
To further probe the role of Cys-266, two double mutant constructs encoding 
proteins containing Asn instead of Cys at residue 172 and either a Ser instead of Cys at 
residue 266 (TGA1C172N,C266S) or a Asn instead of Cys at residue 260 (TGA1C172N,C260N) 
were created and tested (Figure 4.3). Results indicate that TA:TGA1C172N,C266S interacts 
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weakly with DB:NPR1, while TA:TGA1C172N,C260N interacts with DB:NPR1 (Figure 
4.3). TGA1C172N,C266S was able to transactivate, while TGA1C172N,C260N does not 
transactivate (Figure 4.3). These constructs confirm that Cys-260 is an important residue 
in TGA1’s properties. 
The TGA1C172N,C260N,C266S and TGA1C172N,C260N,C266S,C287S mutants were created to 
determine if Cys-287 affects the properties of TGA1 when none of the other Cys 
residues are present. Both TA:TGA1C172N,C260N,C266S and TA:TGA1C172N,C260N,C266S,C287S 
were able to interact with DB:NPR1 while the corresponding GAL4:DB fusions were 
unable to transactivate (Figure 4.3). These results indicate that Cys-287 does not affect 
the properties of TGA1 either in the presence of the other cysteines (Figure 3.3, see 
section 4.1.3) or in their absence (Figure 4.3). 
A last construct was created to further investigate the significance of Cys-260. A 
construct where all of the cysteines but Cys-260 were mutated (TGA1C172N,C266S,C287S) 
was created and tested. This construct interacts weakly with NPR1 and is capable of 
autonomous transactivation (Figure 4.3). This again supports a major role for Cys-260 in 
TGA1’s properties. 
4.1.4.1 Quantitative analysis of transactivation for TGA1 with mutations at 
multiple cysteine residues 
Quantitative transactivation analysis was also completed on several constructs 
containing the mutation of multiple cysteines. DB:TGA1C172N,C266S showed a decrease 
in transactivation to an average of 21.64 pM MU/µg of protein/min compared to 
DB:TGA1 (Figure 4.5). This value is significantly different to that obtained with 
DB:TGA1 (p=0.05) thus corroborating the β-galactosidase assay results. This value is 
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not significantly different to that obtained with DB:TGA1C172N (p=0.05; Figure 4.4). 
These quantitative data indicate that mutating Cys-172 and Cys-266 simultaneously 
does not have a cumulative effect on TGA1 transactivation. 
DB:TGA1C172N,C266S,C287S showed a decrease in transactivation to an average of  
25.20 pM MU/µg of protein/min compared to DB:TGA1 (Figure 4.5). This value is 
not significantly different from DB:TGA1 (p=0.05). It is significantly higher than 
DB:TGA1C260N and DB:TGA1C260S,C266S. (p=0.05). However, it is noteworthy that 
there was a large amount of variability in results obtained with 
DB:TGA1C172N,C266S,C287S.  
In the GUS assay, DB:TGA1C172N,C260S,C266S and DB:TGA1C172N,C260S,C266S,C287S, 
transactivation levels averaged 10.94 pM MU/µg of protein/min and 13.62 pM MU/µg 
of protein/min respectively (Figure 4.5). These values are not significantly different to 
one another, but are significantly different to that of DB:TGA1, according to Student’s 
t-test (p=0.05). The transactivation levels of these constructs are also not significantly 
different than those of DB:TGA1C260S,C266S or DB:TGA1C260S (Figure 4.4). This 
appears to point to Cys-260 as possessing a key role in TGA1 transactivation, as 
mutating more cysteines does not affect transactivation any further. Also of note is the 
fact that the transactivation levels of DB:TGA1C172N,C260S,C266S and 
DB:TGA1C172N,C260S,C266S,C287S are significantly different than those of the DB:Cruc 
control (p=0.05; Figure 4.5). Since a certain level of transactivation exists even 
without the presence of the cysteines, another domain must also be involved in TGA1 
transactivation. 
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Figure 4.5 Quantitative GUS assay of transactivation of TGA1 with mutation at multiple 
cysteine residues. 
Transactivation levels of TGA constructs and cruciferin when measured using the wild 
type CaMV 35S promoter. Each bar represents the average of six independent GUS 
assays from a total of two independent transformations ± SE.  
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4.2 Attempts to alter transactivation and NPR1 interacting properties of TGA2 
Unlike TGA1, TGA2 does not transactivate in yeast but interacts strongly with 
NPR1 (Figure 4.2; 4.3; 4.4; Després et al., 2000). Therefore, in order to further study the 
influence of TGA1 Cys-172 and Cys-260 in TGA factor properties, a series of chimeric 
genes and site-directed mutants were created using TGA2 as template. These constructs 
were then tested for their potential to alter the properties of this transcription factor. 
As a first step, a TGA2 mutant encoding a protein containing cysteines instead of 
Asn-218 and Ser-224 (TGA2N218C,S224C; Figure 4.2, Figure 4.6), the corresponding 
positions to TGA1 Cys-260 and Cys-266, was created and introduced into yeast cells. β-
galactosidase assay results indicate that this construct still interacts with NPR1 and is 
unable to transactivate (Figure 4.6). Therefore, this mutant behaves the same as TGA2, 
indicating that the addition of Cys residues at positions corresponding to Cys-260 and 
Cys-266 of TGA1 is not sufficient to alter TGA2 properties. 
Given that the N-terminal domain of TGA1 has also been implicated in 
mediating TGA1 transactivation properties (Stonehouse, 2002), I tested the influence of 
this domain on TGA2 properties using a previously synthesized plasmid encoding the N-
terminal of TGA1 including the bZIP domain and the C-terminal of TGA2 (TGA1 bZip/ 
TGA2). This construct interacts with NPR1 and is unable to transactivate (Figure 4.6). 
Therefore, this mutant behaves the same as TGA2, indicating that the N-terminal of 
TGA1 is not sufficient to confer transactivational properties onto TGA2 or prevent its 
interaction with NPR1 (see section 2.6.1; Figure 4.6).  
I next created genes that introduced Cys residues found within the 30 amino acid 
region of TGA1 into the TGA1/TGA2 chimeric protein, ligated them into pBI880 and  
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Figure 4.6 β-galactosidase assay results for TGA1/TGA2 chimeric and site-directed 
mutants used in this study. 
Schematic representation of TGA1 (orange), TGA2 (blue) constructs showing the bZip 
domain of each (lighter shade) and location of point mutations (coloured bars). β-
galactosidase assay results for transactivation and NPR1 interaction indicated by – 
(white), +/- (faint blue), and + (blue) after 24 hours. The +/- symbol is used to indicate 
when the blue colour observed was considerably less than the positive control 
(interaction between NPR1 and TGA2). Transactivation results were obtained from 
mutant constructs fused to the GAL4 DB domain in yeast cells coexpressing cruciferin 
fused to the GAL4 TA domain. NPR1 interaction results were obtained from mutant 
constructs fused to the GAL4 TA domain in yeast cells coexpressing NPR1 fused to the 
GAL4 DB domain. Drawings are not to scale. 
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pBI881 and transformed them into yeast cells. None of these constructs, 
TGA1bZip/TGA2N218C,S224C, TGA1bZip/TGA2N218C, or TGA1bZip/TGA2S224C 
transactivated while all still interacted with NPR1 (Figure 4.6). 
 TGA2 possesses a single Cys residue, located at amino acid 186 (Figure 4.2). To 
test for the possibility that this residue participates in a disulfide that is affecting the 
properties of TGA2, it was targeted for mutation to phenylalanine (F), the corresponding 
residue from TGA1 (Figure 4.6). This construct, TGA1bZip/ TGA2C186F, was transferred 
into pBI880 and pBI881 which were transformed into yeast cells. Similar to TGA2, This 
construct did not transactivate but did interact with NPR1. 
If a disulfide bond between Cys-172 and Cys-260 of TGA1 is crucial for the 
changes observed in TGA1 (see section 4.1.3.1), then perhaps the presence of a Cys in 
the corresponding residues may be necessary to see the equivalent change in TGA2. The 
final plasmid created encodes a protein that includes both of the corresponding TGA1 
Cys-172 and Cys-260 residues, TGA1bZip/TGA2N130C,N281C, which was transferred into 
pBI880 and pBI881 (Figure 4.6). This construct interacted with NPR1 and did not 
transactivate (Figure 4.6). These results indicate that the presence of the N-terminal of 
TGA1 in conjunction with the Cys residues implicated in the having the greatest affect 
on TGA1 function is not sufficient to alter TGA2 properties.  
4.3 Identification of a trans-repression domain in TGA2 
 Attempts to change the properties of TGA2, using the domains identified in 
TGA1 as being important for functionality, have thus far failed. This suggests that amino 
acids other than the cysteines and those in the N-terminal play a key role in determining 
TGA2’s properties.  
 55
One possibility to explain lack of transactivation is the presence of a repressor 
domain within TGA2. In an attempt to identify such a domain, I tested additional 
chimeric TGA1/TGA2 genes that had been previously created (Figure 4.7). I ligated 
these genes into pBI880 and pBI881, and introduced the resulting plasmids into yeast 
and tested colonies for LacZ expression by β-galactosidase assays. 
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Figure 4.7 β-galactosidase assay results for TGA1/TGA2 chimeric and site-directed 
mutants used in this study. 
Schematic representation of TGA1 (orange), TGA2 (blue) constructs showing the bZip 
domain of each (lighter shade) and location of point mutations (coloured bars). β-
galactosidase assay results for transactivation and NPR1 interaction indicated by – 
(white), +/- (faint blue), and + (blue) after 24 hours. The +/- symbol is used to indicate 
when the blue colour observed was considerably less than the positive control. 
(interaction between NPR1 and TGA2). Transactivation results were obtained from 
mutant constructs fused to the GAL4 DB domain in yeast cells coexpressing cruciferin 
fused to the GAL4 TA domain. NPR1 interaction results were obtained from mutant 
constructs fused to the GAL4 TA domain in yeast cells coexpressing NPR1 fused to the 
GAL4 DB domain. Drawings are not to scale. 
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One gene encoded a chimeric protein that included the N-terminal of TGA1 up to 
the bZip domain, TGA2 up to the GGFR sequence and the C-terminal of TGA1 (TGA1 
bZip/ TGA2 GGFR/ TGA1; see Figure 4.1 for location of GGFR sequence). TA:TGA1 
bZip/ TGA2 GGFR/ TGA1 interacted with DB:NPR1 while DB:TGA1 bZip/ TGA2 
GGFR/ TGA1 is unable to transactivate (Figure 4.7). The section of TGA1 replaced by 
TGA2 in the above chimeric (TGA1 bZip/ TGA2 GGFR/ TGA1) includes only one Cys 
(Cys-172). Earlier experiments had indicated that modification of this Cys enables the 
mutant protein to interact with NPR1, and reduced the transactivation properties (see 
TGA1C172N, Figure 4.2, 4.4). The observation that DB:TGA1 bZip/ TGA2 GGFR/ TGA1 
cannot transactivate suggested that the area of TGA2 between the bZIP and the GGFR 
may contain a repressor domain. To further localize this putative domain, I tested 
another chimeric protein in which the TGA1 sequences extend past the bZIP and Cys-
172 until the residues LHGH (TGA1 LHGH/ TGA2 GGFR/ TGA1). TA:TGA1 LHGH/ 
TGA2 GGFR/ TGA1 is unable to interact with DB:NPR1 while DB:TGA1 LHGH/ 
TGA2 GGFR/ TGA1 is able to transactivate (Figure 4.7). These results suggest that the 
region between the bZIP and LHGH of TGA2 (Figure 4.1) may contain a putative 
repressor domain. This domain is also important for mediating the interaction with 
NPR1, since substitution of the corresponding region from TGA1 abolishes the 
interaction between TGA2 and NPR1 (compare results of TGA1 LHGH/ TGA2 GGRF/ 
TGA1 and TGA1 bZip/ TGA2 GGFR/ TGA1, Figure 4.7). 
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CHAPTER 5: DISCUSSION 
 
 
 Following the identification of TGA factors as proteins capable of binding the 
as-1 DNA element in 1989 (Katagiri et al., 1989; Lam et al., 1989), much research has 
focused on determining their function in planta. A breakthrough came in the late 1990s, 
when TGA factors were found to interact with the disease resistance protein NPR1 
(Zhang et al., 1999; Després et al., 2000; Zhou et al., 2000). Subsequent research 
established that NPR1 is an important regulator of TGA factor function in vitro and in 
planta (Després et al., 2000; Fan and Dong, 2002; Johnson et al., 2003). Very recently, 
analysis of a mutant lacking all three group II Arabidopsis TGA factors (TGA2, TGA5, 
TGA6) confirmed the need for these transcription factors for SA-induced PR-1 
expression and SAR (Zhang et al., 2003).  
Although the above studies clearly indicate a role for TGA factors in disease 
resistance, little attention has been paid to identifying protein domains required for 
function or modes of regulation. My project not only identifies elements necessary for 
protein function more precisely, but also proposes a method by which they may be 
regulated.  
 Despite the fact that they share over 50% amino acid identity, the Arabidopsis 
TGA1 and TGA2 differ in their ability to interact with NPR1 and transactivate in yeast. 
This prompted the laboratory to create chimeric proteins between these two TGA 
factors, in an effort to identify functionally relevant protein domains. I subsequently 
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created additional chimeric genes and used site-directed mutagenesis to identify 
individual amino acids regulating TGA function. 
5.1 Cysteines 260 and 266 of TGA1 affect interaction with NPR1 
Arabidopsis TGA1 and TGA4 are unique within the TGA family as they are the 
only members unable to interact with the key disease regulatory protein, NPR1, in the 
yeast two-hybrid system (Zhang et al., 1999; Després et al., 2000; Zhou et al., 2000). 
Using a domain swapping approach a thirty amino acid region in TGA2 was identified 
as being crucial for interaction with NPR1 (Després et al., 2003). Within this region 
many residues are conserved between two or more TGA factors, with several being 
conserved in all seven of the Arabidopsis TGA factors examined. The conserved nature 
of TGA factors leads to the assumption that their divergent properties are due to slight 
variations in amino acid sequence. To examine this possibility, the region was scanned 
for residues conserved within TGA1 and TGA4 but different than the conserved residue 
found in the remaining TGA factors. Only one residue fulfilled the parameters of the 
search; a Cys residue corresponding to amino acid 266 of TGA1 and 262 of TGA4 
(Figure 4.1). Since cysteines possess the unique ability to form disulfide bonds between 
their sulfhydryl side chains, the other Cys present in the 30 amino acid region, 
corresponding to residue 260 of TGA1 and 256 of TGA4, was also chosen for further 
study.  
Using site-directed mutagenesis, mutant TGA1 genes were created to encode 
proteins containing the corresponding amino acids found in TGA2 (asparagine and 
serine, respectively) in place of cysteines 260 and 266 (TGA1C260N,C266S and 
TGA4C256S,C262S). Each of these SDM constructs, unlike the Cys-containing wild type 
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protein, interacted with NPR1 in yeast. Using a novel transient expression assay 
conceptually similar to the yeast two-hybrid system, the TGA1 SDM was also shown to 
interact with NPR1 when plasmids encoding both genes were transfected into 
Arabidopsis leaves by biolistics (Després et al., 2003). When each Cys was mutated 
separately and tested in yeast, the TGA1C266S SDM construct appeared to interact with 
NPR1 weakly whereas the TGA1C260N SDM construct interacted with NPR1 strongly. 
These results indicate that while both residues affect the ability of TGA1 to interact with 
NPR1, Cys-260 may play a more prominent role. These results demonstrate that it is 
possible to dramatically change the properties of TGA1/TGA4 by modifying key Cys 
residues and imply that these proteins possess all of the structural elements necessary for 
interaction with NPR1.  
If TGA1 and TGA4 possess all of the elements required for NPR1 interaction, 
the question then arises: how do the Cys residues regulate these proteins’ properties such 
that they are not capable of interacting with NPR1 in yeast? The answer is most likely 
found in the property unique to Cys residues; disulfide bond formation. Reversible 
disulfide bond formation has been shown to regulate the properties of a number of 
cytosolic and nuclear proteins including transcription factors. One well-studied example 
is the prokaryotic transcription factor OxyR (for review, see Kim et al., 2002). The 
cysteines of OxyR exist in a reduced state under normal conditions, but in the presence 
of oxidative conditions an intramolecular disulfide bond is formed. The disulfide bond 
changes the conformation of the protein to allow for interaction with RNA polymerase 
and thus initiates transcription of its target genes (Storz and Tartaglia, 1992; Zheng et 
al., 2001).  
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Since no other amino acids can be oxidized to form a disulfide bond, it is 
generally accepted that mutation of cysteines to other amino acids will mimic the 
reduced state of this residue. Thus, the observation that TGA1/TGA4 SDM are capable 
of interacting with NPR1 in yeast, while the wild types cannot, suggests that (1) only the 
reduced TGA1/TGA1 interact with NPR1 and (2) TGA1/TGA4 exist in an oxidized 
form in yeast cells. Using an in vitro assay that distinguishes between sulfhydryls and 
disulfides, Després et al. (2003) confirmed that TGA1 is predominantly oxidized in 
yeast cells. Furthermore, this group demonstrated that the reduced and oxidized forms of 
TGA1 produced in vitro displayed slightly different mobilities during gel electrophoresis 
under non-reducing conditions. This change in mobility was not observed when Cys-260 
was mutated. Together, these results suggest that TGA1 forms an intramolecular 
disulfide bond involving Cys-260 under oxidizing conditions. Formation of this disulfide 
bond in yeast or plant cells could mask or alter a binding surface in TGA1 required for 
interaction with NPR1. Because the TGA1/TGA4 SDMs lack the critical cysteines, they 
cannot form the disulfide bond, regardless of redox conditions, and thus constitutively 
interact with NPR1.  
Assuming that the redox state of TGA1 and/or TGA4 is crucial for interaction 
with NPR1, the next question of relevance is: how is the redox state of these proteins 
regulated in plants? By combining the assay that distinguished between protein 
sulfhydryls and disulfides with western blot detection using antibodies specific to 
TGA1/TGA4, Després et al. (2003) found that unelicited (resting) Arabidopsis leaves 
contain roughly equal proportions of oxidized and reduced forms of these TGA factors. 
In contrast, leaves treated with SA for 24 hours contained almost exclusively reduced 
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TGA1/TGA4. These results indicate that SA treatment leads to reduction of 
TGA1/TGA4 cysteines. This is consistent with the findings of Mou et al. (2003) who 
measured a net increase in the ratio of reduced to oxidized glutathione, the major redox 
buffer present in plant cells, in Arabidopsis leaves following treatment with INA, a 
biologically active analog of SA. Therefore, it appears that treatment with SA or an SA 
analog leads to a net reduction in the cytoplasmic redox status, which in turn brings 
about the reduction of TGA1/TGA4 cysteines. 
Using the transient plant two-hybrid assay, Després et al. (2003) tested 
interaction of NPR1 and TGA1 in Arabidopsis leaves. In resting leaves very little 
interaction between NPR1 and TGA1 was observed while in leaves treated with SA a 
significant amount of interaction was detected. When the experiment was repeated using 
the TGA1 SDM, interaction between the two proteins was high regardless of SA 
treatment. This is consistent with the model proposed above, in which only the reduced 
state of TGA1 is competent to interact with NPR1 and that mutagenesis of the cysteines 
mimics the reduced state of TGA1.  
What then is the functional significance of the redox-mediated interaction 
between TGA1 and NPR1? NPR1 was previously reported to enhance the DNA-binding 
activity of interacting TGA factors in vitro (Després et al., 2000) and in vivo (Fan and 
Dong, 2002). In vivo, NPR1, together with SA, is both required for the binding of TGA2 
and TGA3 to the PR-1 promoter (Johnson et al., 2003) and for TGA2-mediated gene 
activation (Fan and Dong, 2002). Després et al. (2003) first tested whether the DNA 
binding activity of TGA1, in the absence of NPR1, was altered by redox conditions. 
Using electrophoretic mobility shift assays (EMSAs) they found no differences in 
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binding affinity, regardless of excess presence of reducing or oxidizing agents. Addition 
of NPR1 to the oxidized form of TGA1 also did not alter DNA-binding. Only when 
NPR1 was added to the reduced form of TGA1 was a stimulation of DNA binding 
observed. 
Together, my results along with those of Després et al. (2003) are consistent with 
a model wherein the pool of TGA1/TGA4 in resting Arabidopsis cells is substantially 
oxidized. TGA1 forms an intramolecular disulfide bridge which alters its conformation, 
preventing interaction with NPR1. In the absence of NPR1 interaction, binding of TGA1 
to cognate cis-elements is low. When SA accumulates inside Arabidopsis cells, as 
occurs following pathogen infection, TGA1 becomes reduced and adopts a conformation 
allowing interaction with NPR1. Binding of NPR1 to reduced TGA1 stimulates its DNA 
binding activity to cognate cis-elements leading to the activation of defence genes and 
ultimately to enhanced disease resistance (Figure 5.1). 
5.2 Cysteine 260 and cysteine 266 affect TGA1’s ability to transactivate 
In addition to differing in ability to interact with NPR1, Arabidopsis TGA factors 
also possess differing abilities in regard to autonomous transactivation (Stonehouse, 
2002). Therefore, the domain swapping constructs between TGA1 and TGA2 were 
exploited once again to identify regions important for transactivation. Instead of fusing 
the chimeric proteins with the GAL4-TA (as used to determine interaction with NPR1) 
they were fused with the GAL4-DB and tested in yeast for their ability to initiate 
transcription of the β-Galactosidase reporter gene. The same thirty amino acid region 
identified as being important for interaction with NPR1 was also identified to be crucial 
for transactivation. Again the two cysteines located within this region were found to be  
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Figure 5.1 A model depicting redox control of TGA1 on binding activity (modified from 
Després et al., 2003). 
In resting Arabidopsis cells TGA1 forms intramolecular disulfide bridges, which 
prevents interaction with NPR1. In response to a redox signal, such as pathogen-induces 
SA (Mou et al., 2003), TGA1 is reduced which leads to a conformation change that 
allows interaction with NPR1. 
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critical for TGA1 function. When the SDM TGA1C260N,C266S and TGA4C256S,C262S 
constructs were fused to the GAL4-DB an observable decrease in transactivation was 
detected compared to the wild type. This confirmed that the cysteines do play a role in 
controlling the proteins’ transactivational ability. When each Cys was mutated 
separately and analyzed using the β-galactosidase assay, the TGA1C266S SDM construct 
displayed the same transactivational level as the wild type, whereas the TGA1C260N SDM 
construct appeared to only transactivate weakly compared to the wild type.  
Since the β-galactosidase assay is not quantitative, the same GAL4-TA 
constructs were transferred into yeast cells containing the GUS reporter gene under the 
control of the cognate TGA factor promoter element (as-1) and quantitative assays were 
performed to assess transactivation. These tests revealed that simultaneous mutation of 
both Cys-260 and Cys-266 statistically reduced transactivation (2.5-fold) of TGA1, thus 
confirming the findings of the β-galactosidase assay that the cysteines are important for 
TGA1 transactivation. Furthermore, quantitative tests confirmed that mutation of Cys-
266 had only minor effects (albeit statistically significant) on TGA1 transactivation, 
while mutation of Cys-260 affected transactivation to the same extent as when both 
cysteines are mutated. Therefore, it appears that the reduction in transactivation in the 
TGA1C260N,C266S SDM can be attributed predominantly to Cys-260.  
The results described above do not entirely dismiss a potential role of Cys-266 in 
regulating transactivation. Indeed there is a significant decrease in transactivation in the 
TGA1C266N SDM compared to that of the wild type. At this time it can only be said that 
the contribution of Cys-266 to TGA1’s transactivation potential in yeast is not as great 
as that of Cys-260. It is also important to point out that although the TGA1C260N,C266S and 
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TGA1C260S SDMs display a great decrease in transactivation, this property is not entirely 
abolished in either assay exploited. The continued presence of transactivation therefore 
leads to the conclusion that while the cysteines contribute significantly to 
transactivation, other elements must also be involved.  
Deletion mutations of TGA1 determined that the N-terminal of TGA1 up to the 
basic domain is crucial for transactivation (Stonehouse, 2002). This is supported by 
studies of tobacco TGA factors TGA1a and TGA2.1 where the N-terminal was found to 
be required for transactivation (Pascuzzi et al., 1998; Niggeweg et al., 2000). Together 
with the above information, my results indicate that TGA1 contains a bipartite 
transactivation domain. Although we understand that the N-terminal and Cys-260 and 
Cys-266 participate in TGA1 transactivation in yeast, their relevance in plants has yet to 
be studied. As a first step, the SDM constructs are being tested for transactivation using 
a transient assay similar to the one described in Després et al. (2003) (C. Després, 
personal communication). The constructs are also being expressed in the context of 
transgenic plants to determine the consequences on PR gene expression and disease 
resistance (P. Fobert, personal communication). In the case of transgenic plants, 
determining the function of these proteins in the wild type genetic background has been 
greatly hindered by the presence of the redox-sensitive, wild type TGA1 and TGA4 
proteins. Loss-of-function mutations in the genes encoding these proteins may facilitate 
analysis. However, functional redundancy within the TGA family, as demonstrated for 
group II factors (TGA2, TGA5, TGA6; Zhang et al., 2003), is also likely to be 
problematic for TGA1 and TGA4.  
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Based on the hypothesis that mutation of Cys residues mimic the reduced state of 
this amino acid, my data in yeast suggest that TGA1 would transactivate preferentially 
under oxidizing conditions. The demonstration that almost all TGA1 cysteines are 
oxidized in yeast cells (Després et al. 2003) and that TGA1 transactivates in these cells 
is consistent with the hypothesis. Preliminary results indicate that TGA1 does in fact 
transactivate in resting Arabidopsis cells (C. Després, unpublished). Based on the 
observation that SA leads to reduction of TGA1 cysteines (Despres et al., 2003), a 
reduction in transactivation when SA levels increase, such as following pathogen 
challenge, is expected to be observed. Therefore the TGA1C260N,C266S and TGA1C260S 
constructs would be predicted to mimic the reduced state in plants and would be unable 
to transactivate in the plant system. Therefore under these circumstances TGA1 may act 
as a transcriptional repressor following SA treatment. 
5.3 The effect of the other cysteines in TGA1 
 In addition to the two Cys residues present in the 30 amino acid NPR1-
interaction domain, TGA1 contains two other Cys residues. In the light of the results 
discussed in sections 4.2 and 4.3, it seemed relevant to test whether these additional Cys 
residues could also be involved in regulating TGA1 properties. To this end, site directed 
mutagenesis was used to change each Cys individually to encode the corresponding 
amino acids found in TGA2 (asparagine and serine) (TGA1C172N and TGA1C287S). These 
mutant constructs were placed in a GAL4 TA containing vector, co-transformed into 
yeast cells with GAL4 DB:NPR1 and tested for protein interaction using the β-
galactosidase reporter gene. While the mutation of Cys-287 does not appear to affect 
protein interaction, as no interaction is observed, mutation of Cys-172 enabled the 
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protein to interact with NPR1. The significance of Cys-172 in protein function versus 
that of Cys-287 is not entirely unexpected as Cys-172 is conserved between TGA1 and 
TGA4 whereas Cys-287 is not. This again raises the question of the possibility of a 
disulfide bond forming between Cys-172 and Cys-260 which may mediate TGA1:NPR1 
interaction. However, additional research will be required to further assess the potential 
role of these Cys residues in regulating TGA1 function. For example, although Cys-260 
has been shown to participate in a disulfide bond in vitro (Després et al., 2003), this has 
not yet been demonstrated for Cys-172. Furthermore, neither Cys residue has been 
shown to form a disulfide bond in planta.  
To test whether the mutation of multiple cysteines would have an additive effect 
on protein interaction with NPR1, several constructs containing simultaneous mutation 
of multiple cysteines were created. An emphasis was placed on studying the effects of 
the two cysteines identified to influence TGA1:NPR1 interaction the greatest, Cys-172 
and Cys-260. All of the mutant constructs created, TGA1C172N,C260S, 
TGA1C172S,C260N,C266S, and TGA1C172S,C260N,C266S,C287S, interacted with NPR1 to the same 
extent as the TGA1C172N and TGA1C260N constructs. Therefore mutating multiple 
cysteines within TGA1 does not affect NPR1 interaction to a greater extent. This may be 
because the contribution to protein interaction of the remaining cysteines residues is 
marginal compared to the two key cysteines. However, it is important to remember that 
the β-galactosidase assay is only qualitative and may not be sensitive enough to detect 
slight variances in protein interaction. Quantitative tests in yeast or in plants will be 
necessary to resolve such changes. Although I did attempt such tests in yeast, they 
proved difficult to establish and were discontinued. 
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The mutant constructs were also placed in a vector containing the GAL4 DB and 
co-transformed with GAL4 TA:cruciferin into yeast cells and tested for transactivation. 
Using the β-galactosidase reporter gene it was found that the TGA1C172N, TGA1C287S, 
TGA1C172N,C266S SDM and TGA1C172S,C266S,C287S constructs transactivate, indicating that 
Cys-172 and Cys-287 are not crucial for TGA1 transactivation. In contrast, the 
TGA1C172S,C260N,C266S, TGA1C172S,C260N,C266S,C287S SDM constructs do not transactivate. 
To confirm the observations from the β-galactosidase assays the same constructs were 
transferred into yeast cells containing the GUS reporter gene under the control of the as-
1 element and quantitative assays were performed to assess transactivation. These tests 
revealed that Cys-172, Cys-266, and Cys-287 affect transactivation slightly and only 
Cys-260 affects transactivation to a large extent. Any of the constructs containing 
mutation of multiple cysteines, that included the mutation of Cys-260, only had a 
decrease in transactivation equal to what is seen in the Cys-260 single SDM. Any 
multiple mutant constructs that did not include the mutation of Cys-260 had 
transactivation levels similar to the levels seen in the single mutation constructs. This 
confirms that while three of the four Cys residues of TGA1 (172, 260 and 266) affect the 
protein’s ability to transactivate, Cys-260 possesses the greatest ability to affect 
transactivation. This also confirms that mutation of more than one Cys does not appear 
to interfere any further with transactivation capabilities than with only one Cys mutated. 
This is important to note because TGA1 appears to only create intramolecular disulfide 
bonds (Després et al., 2003). These results indicate that only Cys-260 is key to the 
formation of this disulfide bond as transactivation is only slightly reduced when either 
Cys-172 or Cys-266 are mutated. It is not known if either of Cys-172 or Cys-266 is the 
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preferred partner of Cys-260 in disulfide bond formation. It is possible that Cys-260 is 
capable of forming disulfide bonds with both of these residues, or preferentially interacts 
with one or the other under certain conditions. Furthermore, it is not known whether 
Cys-260 is capable of forming a disulfide bond with an alternative Cys if its preferred 
partner is mutated, nor is it known what the functional consequences of the novel 
bonding may have on TGA1 properties.  
 In addition to disulfide bond formation, it has been recently proposed that 
conjugation of Cys residues with glutathione moieties (glutathionylation) represents an 
alternative post-translational modification for protein cysteines (Shelton et al., 2005). Of 
note, glutathionylated Cys residues would behave as oxidized cysteines in the assays 
performed by Després et al. (2003). Thus, glutathionylation of Cys-260 would not 
require the participation of any other TGA1 cysteines which may explain why mutation 
of these other cysteines has only minor consequences on TGA1 function (compared to 
mutation of Cys-260).  
 Throughout this study, discrepancies were occasionally observed between results 
of β-galactosidase assay and MUG tests. In such instances, I typically sides with results 
from the latter assay, since it is quantitative and more sensitive, being based on the 
production of a fluorescence product. It is possible that some of the discrepancies may 
also be attributed to changes in DNA binding properties of TGA factors, which would 
only be detected in the MUG assays, since it relied on binding to the cognate cis-element 
of TGA factors.  
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5.4 TGA2 properties 
 Redox regulation through the reversible formation of disulfide bonds between 
Cys residues may not be a phenomenon limited to TGA1 and TGA4. Each subgroup of 
the TGA family possesses unique conserved Cys residues; members of subgroup I 
contain three conserved Cys residues, whereas members of subgroups II and III both 
contain one conserved Cys residue. The conserved nature of these residues is consistent 
with the theory that they are essential for protein function, perhaps through redox 
regulation. The possibility that all TGA factors may be controlled by redox conditions 
does not exclude the possibility that the regulation may differ between the subgroups or 
even between the factors in each group. TGA1 forms intramolecular disulfide bonds, 
most likely between Cys-260 and either Cys-172 or Cys-266, where the other TGA 
factors probably form intermolecular disulfide bonds due to the limited number of 
conserved Cys residues present in the protein. TGA2 possesses a single Cys residue and 
it is impossible for intramolecular disulfide bonds to form. 
 In yeast, TGA1 transactivates but is unable to interact with NPR1. By virtue of 
mutating only one Cys residue TGA1 was able to interact with NPR1 proving that it 
possesses all the requirements necessary for interaction. TGA2 however does not 
transactivate in yeast, but it does interact with NPR1. If regulation by redox status is 
conserved among TGA factors then by extension TGA2 may also possess all the 
elements necessary for transactivation it only needs its redox state switched for the 
property to be observed. To test this we applied the knowledge gained from TGA1’s 
properties against that of TGA2. Initially only the Cys residues identified in TGA1 to 
participate in the disulfide bond were targeted to be studied in TGA2. A construct that 
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incorporated the corresponding Cys residues from TGA2 (TGA2N218C,S224C) interacted 
with NPR1 and did not transactivate, indicating that the presence of these cysteines is 
not sufficient for transactivation. The largest variation in amino acid sequence between 
TGA1 and TGA2 is the presence of a forty five amino acid region at the N-terminal end 
of the protein. As this region has been shown to be crucial for transactivation in TGA1 
(Stonehouse, 2002) its absence in TGA2 may preclude transactivation in yeast. 
Therefore a series of constructs were created in which the N-terminal of TGA1 was 
swapped for that of TGA2 and different combinations of residues were mutated to 
encode that of a Cys residue (TGA1bZip/TGA2N218C, TGA1bZip/TGA2S224C, 
TGA1bZip/TGA2N218C,S224C, and TGA1bZip/TGA2N130C,N218C). None of these constructs 
where able to transactivate in yeast indicating that other features are required.  
 At least two possibilities remain that may affect the ability for TGA2 to 
transactivate in yeast. The first is that the conserved Cys residue located at residue 186 
may be forming a disulfide bond which is inhibiting the protein to transactivate. To 
account for this a construct containing the N-terminal of TGA1 and the C-terminal of 
TGA2 including the mutation of this Cys to encode the amino acid phenylalanine, the 
corresponding residue in TGA1 (TGA1bZip/TGA2C186F) was created, but like the other 
constructs did not transactivate in yeast and still interacted with NPR1. Thus, I was 
unable to obtain experimental evidence to support the participation of cysteine residues 
in the regulation of TGA2. 
 A second possibility is that a transactivational repression domain is present 
within TGA2. This is apparent in the quantitative assay as TGA2 displays a decrease in 
transactivation to a level significantly lower than background levels. Two constructs 
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may be important in identifying a repression domain, TGA1 LHGH/ TGA2 GGFR/ 
TGA1 and TGA1 bZip/ TGA2 GGFR/ TGA1. The chimeric construct TGA1 LHGH/ 
TGA2 GGFR/ TGA1 does not interact with NPR1 but does transactivate whereas the 
chimeric construct TGA1 bZip/ TGA2 GGFR/ TGA1 interacts with NPR1 and does not 
transactivate in yeast. The only difference between these two constructs is the presence 
of a 34 amino acid region of TGA1 found in the TGA1 LHGH/ TGA2 GGFR/ TGA1. 
To confirm that the region does contain a repression domain constructs would need to be 
made that swapped this region between TGA1 and TGA2. If a repression domain does 
exist it would be expected that the transactivational levels of a TGA2 construct lacking 
the domain would rise to at least background levels whereas the transactivational levels 
of a TGA1 construct containing the domain would dramatically decrease.  
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